{
  "test_run_id": "test_run_2025-12-16_08-06-49",
  "timestamp": "2025-12-16T08:06:49.159770",
  "configuration": {
    "api_base_url": "https://gemini-chatbot-480267397633.us-central1.run.app",
    "num_tests": 50,
    "parallel": 5,
    "timeout": 120,
    "save_reports": true,
    "report_dir": "automated_testing/reports"
  },
  "summary": {
    "total_tests": 5,
    "passed": 0,
    "failed": 5,
    "pass_rate": 0.0,
    "average_overall_score": 51.6,
    "average_response_time": 28.230123860187945
  },
  "metrics": {
    "crash_prevention": {
      "average_score": 80.0,
      "passed": 4,
      "failed": 1
    },
    "eligibility_accuracy": {
      "average_score": 0.0,
      "passed": 0,
      "failed": 5
    },
    "conversation_quality": {
      "average_score": 48.0,
      "passed": 3,
      "failed": 2
    },
    "edge_case_handling": {
      "average_score": 100.0,
      "applicable_tests": 1,
      "passed": 5
    },
    "performance": {
      "average_response_time": 28.230123860187945,
      "passed": 0
    }
  },
  "failure_summary": {
    "total_failures": 67,
    "by_type": {
      "eligibility_logic_error": 5,
      "conversation_quality_issue": 55,
      "performance_issue": 5,
      "crash": 2
    }
  },
  "failures": [
    {
      "test_id": "AUTO_TEST_targeted_diabetes_001",
      "patient_profile": {
        "age": 65,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "eligibility_logic_error",
      "reason": "No eligibility determination found in conversation",
      "likely_location": "core/prescreening/gemini_prescreening_manager.py:evaluate_eligibility()",
      "severity": "high"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_001",
      "patient_profile": {
        "age": 65,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_001",
      "patient_profile": {
        "age": 65,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_001",
      "patient_profile": {
        "age": 65,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_001",
      "patient_profile": {
        "age": 65,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_001",
      "patient_profile": {
        "age": 65,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_001",
      "patient_profile": {
        "age": 65,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_001",
      "patient_profile": {
        "age": 65,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_001",
      "patient_profile": {
        "age": 65,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_001",
      "patient_profile": {
        "age": 65,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_001",
      "patient_profile": {
        "age": 65,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_001",
      "patient_profile": {
        "age": 65,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_001",
      "patient_profile": {
        "age": 65,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_001",
      "patient_profile": {
        "age": 65,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_001",
      "patient_profile": {
        "age": 65,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_001",
      "patient_profile": {
        "age": 65,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_001",
      "patient_profile": {
        "age": 65,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_001",
      "patient_profile": {
        "age": 65,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_001",
      "patient_profile": {
        "age": 65,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_001",
      "patient_profile": {
        "age": 65,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_001",
      "patient_profile": {
        "age": 65,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_001",
      "patient_profile": {
        "age": 65,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_001",
      "patient_profile": {
        "age": 65,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_001",
      "patient_profile": {
        "age": 65,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_001",
      "patient_profile": {
        "age": 65,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_001",
      "patient_profile": {
        "age": 65,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_001",
      "patient_profile": {
        "age": 65,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_diabetes_001",
      "patient_profile": {
        "age": 65,
        "conditions": [
          "Type 2 Diabetes",
          "Hypertension"
        ],
        "medications": [
          "Metformin",
          "Lisinopril"
        ]
      },
      "type": "performance_issue",
      "avg_response_time": 26.507058545947075,
      "max_response_time": 55.60342597961426,
      "severity": "low",
      "recommendation": "Investigate slow API responses or Gemini API delays"
    },
    {
      "test_id": "AUTO_TEST_random_001",
      "patient_profile": {
        "age": 59,
        "conditions": [
          "Hidradenitis Suppurativa"
        ],
        "medications": [
          "Antibiotics",
          "Adalimumab",
          "Humira"
        ]
      },
      "type": "eligibility_logic_error",
      "reason": "No eligibility determination found in conversation",
      "likely_location": "core/prescreening/gemini_prescreening_manager.py:evaluate_eligibility()",
      "severity": "high"
    },
    {
      "test_id": "AUTO_TEST_random_001",
      "patient_profile": {
        "age": 59,
        "conditions": [
          "Hidradenitis Suppurativa"
        ],
        "medications": [
          "Antibiotics",
          "Adalimumab",
          "Humira"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I'm here to help you find clinical trials. What co...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_random_001",
      "patient_profile": {
        "age": 59,
        "conditions": [
          "Hidradenitis Suppurativa"
        ],
        "medications": [
          "Antibiotics",
          "Adalimumab",
          "Humira"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: Great! I found 5 clinical trial(s) available in Ba...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_random_001",
      "patient_profile": {
        "age": 59,
        "conditions": [
          "Hidradenitis Suppurativa"
        ],
        "medications": [
          "Antibiotics",
          "Adalimumab",
          "Humira"
        ]
      },
      "type": "performance_issue",
      "avg_response_time": 31.48797414984022,
      "max_response_time": 57.816179037094116,
      "severity": "low",
      "recommendation": "Investigate slow API responses or Gemini API delays"
    },
    {
      "test_id": "AUTO_TEST_targeted_gout_000",
      "patient_profile": {
        "age": 45,
        "conditions": [
          "Gout",
          "Hypertension"
        ],
        "medications": [
          "Lisinopril"
        ]
      },
      "type": "crash",
      "error_type": "timeout",
      "error_message": "Unknown error",
      "likely_location": "aiohttp timeout in conversation_simulator.py or slow Gemini API response",
      "severity": "critical"
    },
    {
      "test_id": "AUTO_TEST_targeted_gout_000",
      "patient_profile": {
        "age": 45,
        "conditions": [
          "Gout",
          "Hypertension"
        ],
        "medications": [
          "Lisinopril"
        ]
      },
      "type": "crash",
      "error_type": "conversation_failure",
      "error_message": "",
      "likely_location": "Unknown - check full error trace",
      "severity": "critical"
    },
    {
      "test_id": "AUTO_TEST_targeted_gout_000",
      "patient_profile": {
        "age": 45,
        "conditions": [
          "Gout",
          "Hypertension"
        ],
        "medications": [
          "Lisinopril"
        ]
      },
      "type": "eligibility_logic_error",
      "reason": "Prescreening flow did not complete",
      "final_state": "failed",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py",
      "severity": "high"
    },
    {
      "test_id": "AUTO_TEST_targeted_gout_000",
      "patient_profile": {
        "age": 45,
        "conditions": [
          "Gout",
          "Hypertension"
        ],
        "medications": [
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_gout_000",
      "patient_profile": {
        "age": 45,
        "conditions": [
          "Gout",
          "Hypertension"
        ],
        "medications": [
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_targeted_gout_000",
      "patient_profile": {
        "age": 45,
        "conditions": [
          "Gout",
          "Hypertension"
        ],
        "medications": [
          "Lisinopril"
        ]
      },
      "type": "performance_issue",
      "avg_response_time": 25.071464742933,
      "max_response_time": 36.66876006126404,
      "severity": "low",
      "recommendation": "Investigate slow API responses or Gemini API delays"
    },
    {
      "test_id": "AUTO_TEST_edge_age_000",
      "patient_profile": {
        "age": 75,
        "conditions": [
          "Hypertension"
        ],
        "medications": [
          "Lisinopril"
        ]
      },
      "type": "eligibility_logic_error",
      "reason": "No eligibility determination found in conversation",
      "likely_location": "core/prescreening/gemini_prescreening_manager.py:evaluate_eligibility()",
      "severity": "high"
    },
    {
      "test_id": "AUTO_TEST_edge_age_000",
      "patient_profile": {
        "age": 75,
        "conditions": [
          "Hypertension"
        ],
        "medications": [
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_edge_age_000",
      "patient_profile": {
        "age": 75,
        "conditions": [
          "Hypertension"
        ],
        "medications": [
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_edge_age_000",
      "patient_profile": {
        "age": 75,
        "conditions": [
          "Hypertension"
        ],
        "medications": [
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_edge_age_000",
      "patient_profile": {
        "age": 75,
        "conditions": [
          "Hypertension"
        ],
        "medications": [
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_edge_age_000",
      "patient_profile": {
        "age": 75,
        "conditions": [
          "Hypertension"
        ],
        "medications": [
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_edge_age_000",
      "patient_profile": {
        "age": 75,
        "conditions": [
          "Hypertension"
        ],
        "medications": [
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_edge_age_000",
      "patient_profile": {
        "age": 75,
        "conditions": [
          "Hypertension"
        ],
        "medications": [
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_edge_age_000",
      "patient_profile": {
        "age": 75,
        "conditions": [
          "Hypertension"
        ],
        "medications": [
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_edge_age_000",
      "patient_profile": {
        "age": 75,
        "conditions": [
          "Hypertension"
        ],
        "medications": [
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_edge_age_000",
      "patient_profile": {
        "age": 75,
        "conditions": [
          "Hypertension"
        ],
        "medications": [
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_edge_age_000",
      "patient_profile": {
        "age": 75,
        "conditions": [
          "Hypertension"
        ],
        "medications": [
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_edge_age_000",
      "patient_profile": {
        "age": 75,
        "conditions": [
          "Hypertension"
        ],
        "medications": [
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_edge_age_000",
      "patient_profile": {
        "age": 75,
        "conditions": [
          "Hypertension"
        ],
        "medications": [
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_edge_age_000",
      "patient_profile": {
        "age": 75,
        "conditions": [
          "Hypertension"
        ],
        "medications": [
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_edge_age_000",
      "patient_profile": {
        "age": 75,
        "conditions": [
          "Hypertension"
        ],
        "medications": [
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_edge_age_000",
      "patient_profile": {
        "age": 75,
        "conditions": [
          "Hypertension"
        ],
        "medications": [
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_edge_age_000",
      "patient_profile": {
        "age": 75,
        "conditions": [
          "Hypertension"
        ],
        "medications": [
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_edge_age_000",
      "patient_profile": {
        "age": 75,
        "conditions": [
          "Hypertension"
        ],
        "medications": [
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_edge_age_000",
      "patient_profile": {
        "age": 75,
        "conditions": [
          "Hypertension"
        ],
        "medications": [
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_edge_age_000",
      "patient_profile": {
        "age": 75,
        "conditions": [
          "Hypertension"
        ],
        "medications": [
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_edge_age_000",
      "patient_profile": {
        "age": 75,
        "conditions": [
          "Hypertension"
        ],
        "medications": [
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_edge_age_000",
      "patient_profile": {
        "age": 75,
        "conditions": [
          "Hypertension"
        ],
        "medications": [
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_edge_age_000",
      "patient_profile": {
        "age": 75,
        "conditions": [
          "Hypertension"
        ],
        "medications": [
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_edge_age_000",
      "patient_profile": {
        "age": 75,
        "conditions": [
          "Hypertension"
        ],
        "medications": [
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I'm here to help you find clinical trials. What co...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_edge_age_000",
      "patient_profile": {
        "age": 75,
        "conditions": [
          "Hypertension"
        ],
        "medications": [
          "Lisinopril"
        ]
      },
      "type": "conversation_quality_issue",
      "issue": "Repeated question: I couldn't find height and weight information in y...",
      "severity": "medium",
      "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
    },
    {
      "test_id": "AUTO_TEST_edge_age_000",
      "patient_profile": {
        "age": 75,
        "conditions": [
          "Hypertension"
        ],
        "medications": [
          "Lisinopril"
        ]
      },
      "type": "performance_issue",
      "avg_response_time": 33.924244217574596,
      "max_response_time": 58.63143801689148,
      "severity": "low",
      "recommendation": "Investigate slow API responses or Gemini API delays"
    },
    {
      "test_id": "AUTO_TEST_random_000",
      "patient_profile": {
        "age": 69,
        "conditions": [
          "Osteoarthritis of the Knee"
        ],
        "medications": [
          "Cortisone Injections",
          "Acetaminophen",
          "NSAIDs"
        ]
      },
      "type": "eligibility_logic_error",
      "reason": "No eligibility determination found in conversation",
      "likely_location": "core/prescreening/gemini_prescreening_manager.py:evaluate_eligibility()",
      "severity": "high"
    },
    {
      "test_id": "AUTO_TEST_random_000",
      "patient_profile": {
        "age": 69,
        "conditions": [
          "Osteoarthritis of the Knee"
        ],
        "medications": [
          "Cortisone Injections",
          "Acetaminophen",
          "NSAIDs"
        ]
      },
      "type": "performance_issue",
      "avg_response_time": 24.159877644644844,
      "max_response_time": 58.95304012298584,
      "severity": "low",
      "recommendation": "Investigate slow API responses or Gemini API delays"
    }
  ],
  "detailed_results": [
    {
      "patient_id": "AUTO_TEST_targeted_diabetes_001",
      "patient_profile": {
        "patient_id": "AUTO_TEST_targeted_diabetes_001",
        "profile_type": "targeted",
        "demographics": {
          "age": 65,
          "gender": "male",
          "location": "Atlanta, GA",
          "name": "Test Diabetes Patient",
          "first_name": "Test",
          "last_name": "Patient"
        },
        "medical_history": {
          "primary_condition": "Type 2 Diabetes",
          "conditions": [
            "Type 2 Diabetes",
            "Hypertension"
          ],
          "medications": [
            "Metformin",
            "Lisinopril"
          ],
          "duration_years": 7,
          "a1c": 8.2,
          "blood_glucose": 180
        },
        "expected_behavior": {
          "should_find_trials": true,
          "likely_eligible": true,
          "expected_question_count_range": [
            5,
            9
          ],
          "target_trial_keywords": [
            "diabetes"
          ]
        }
      },
      "conversation_result": {
        "session_id": "AUTO_TEST_targeted_diabetes_001",
        "patient_id": "AUTO_TEST_targeted_diabetes_001",
        "conversation_log": [
          {
            "user_message": "Type 2 Diabetes trials in Atlanta, GA",
            "bot_response": "Great! I found 5 clinical trial(s) available in Atlanta, GA:\n\n**Dr. Robert Springer**\n  \u2022 Type 2 Diabetes (1 trial)\n  \u2022 Female Pattern Hair Loss (Androgenetic Alopecia) (1 trial)\n  \u2022 Obesity (1 trial)\n  \u2022 Idiopathic Gastroparesis (1 trial)\n  \u2022 COVID-19 (1 trial)\n\nWould you like to:\n1. Check your eligibility for any of these trials?\n2. Learn more about a specific condition?\n3. See trials in a different location?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_001",
              "current_state": "trials_shown",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "search_trials",
              "entities_collected": {
                "condition": "Type 2 Diabetes",
                "location": "Atlanta",
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "search_trials",
                "parameters": {
                  "condition": "Type 2 Diabetes",
                  "location": "Atlanta, GA"
                },
                "response_text": "Of course. I can look for Type 2 Diabetes trials in Atlanta, GA for you. Let me see what I can find.",
                "new_state": "showing_trials",
                "collect_entities": [],
                "metadata": {
                  "reasoning": "The user has provided a new location for their trial search. Since I have both the necessary condition ('Type 2 Diabetes') and the new location ('Atlanta, GA'), the correct action is to perform a new search with these updated parameters. The response acknowledges the user's request and confirms the action being taken, updating the search context."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "trials_found": 5,
              "condition": "Type 2 Diabetes",
              "location": "Atlanta, GA",
              "trials_data": [
                {
                  "id": 86,
                  "trial_name": "A Phase 3 Randomized, Double-Blind, Placebo-Controlled, 78-Week Efficacy and Safety Study of VK2735 Administered Subcutaneously for Weight Management in Participants with Type 2 Diabetes who are Obese, or Overweight (VANQUISH-2)",
                  "conditions": "Type 2 Diabetes",
                  "description": "This is a Phase 3, randomized, double-blind, placebo-controlled, multi-center study sponsored by Viking Therapeutics Inc.  This means that some participants will receive VK2735 while others receive a placebo, and neither the participants nor the study staff will know who is receiving which.  The study will last for approximately 88 weeks, including a screening period, 78 weeks of treatment, and a 6-week follow-up period.  The study will be conducted at multiple locations across the US. \n\nThis study is for adults with type 2 diabetes who are obese (BMI \u226530 kg/m\u00b2) or overweight (BMI \u226527 kg/m\u00b2).  You must be willing to attend regular study visits and follow the study procedures. Key exclusion criteria include having a history of pancreatitis, certain heart conditions, or currently taking certain medications.  The study aims to include a diverse group of participants, including those of different ethnic and racial backgrounds and those over 65.  During the study, you will receive either VK2735 or a placebo by weekly injection.  You will need to attend weekly visits for the first 33 weeks, then monthly visits thereafter. \n\nThe study will investigate the effectiveness and safety of VK2735 for weight loss.  Your weight, BMI, waist circumference, blood pressure, blood sugar levels (HbA1c and fasting plasma glucose), and cholesterol levels will be measured.  The primary goal is to see if VK2735 is better than placebo at helping participants lose weight.  Secondary goals include assessing the impact of VK2735 on other health measures like blood sugar control and cholesterol levels.  You will have regular check-ups and assessments, including blood tests, physical exams, and questionnaires about your health and quality of life.",
                  "investigator_name": "Dr. Robert Springer",
                  "site_location": "Atlanta, GA",
                  "protocol_summary": "This is a Phase 3, randomized, double-blind, placebo-controlled, multi-center study sponsored by Viking Therapeutics Inc.  This means that some participants will receive VK2735 while others receive a placebo, and neither the participants nor the study staff will know who is receiving which.  The study will last for approximately 88 weeks, including a screening period, 78 weeks of treatment, and a 6-week follow-up period.  The study will be conducted at multiple locations across the US. \n\nThis study is for adults with type 2 diabetes who are obese (BMI \u226530 kg/m\u00b2) or overweight (BMI \u226527 kg/m\u00b2).  You must be willing to attend regular study visits and follow the study procedures. Key exclusion criteria include having a history of pancreatitis, certain heart conditions, or currently taking certain medications.  The study aims to include a diverse group of participants, including those of different ethnic and racial backgrounds and those over 65.  During the study, you will receive either VK2735 or a placebo by weekly injection.  You will need to attend weekly visits for the first 33 weeks, then monthly visits thereafter. \n\nThe study will investigate the effectiveness and safety of VK2735 for weight loss.  Your weight, BMI, waist circumference, blood pressure, blood sugar levels (HbA1c and fasting plasma glucose), and cholesterol levels will be measured.  The primary goal is to see if VK2735 is better than placebo at helping participants lose weight.  Secondary goals include assessing the impact of VK2735 on other health measures like blood sugar control and cholesterol levels.  You will have regular check-ups and assessments, including blood tests, physical exams, and questionnaires about your health and quality of life.",
                  "total_sites": 4,
                  "similarity_score": 0.7753052578511981
                },
                {
                  "id": 14,
                  "trial_name": "Clinical Trial 250-13951-306",
                  "conditions": "Female Pattern Hair Loss (Androgenetic Alopecia)",
                  "description": null,
                  "investigator_name": "Dr. Robert Springer",
                  "site_location": "Atlanta, GA",
                  "protocol_summary": "This clinical trial aims to investigate the effectiveness and safety of an oral medication called VDPHL01 for treating female pattern hair loss (androgenetic alopecia).  The study will evaluate two different dosing regimens of VDPHL01: twice daily and once daily.  It will compare these regimens against a placebo to see if the medication promotes hair growth and improves patient satisfaction with their hair.\n\nWomen aged 18-65 with mild to moderate hair loss, as measured by the Savin Scale, are eligible to participate.  Key inclusion criteria include good general health, adequate kidney and liver function, and a commitment to maintaining consistent hair care routines throughout the study.  Women who are pregnant, breastfeeding, have certain medical conditions (like uncontrolled blood pressure or a history of heart problems), or have recently used other hair growth treatments are excluded.\n\nThe study will last approximately 13 months and consist of two parts. Part A is a 6-month placebo-controlled period, where participants are randomly assigned to one of four groups: VDPHL01 twice daily, VDPHL01 once daily plus placebo, placebo twice daily, or placebo twice daily.  Part B is a 6-month treatment extension, where those initially receiving placebo will start taking VDPHL01 according to their initial group assignment, while those already on VDPHL01 will continue.  Participants will have regular clinic visits (approximately 11) for assessments including physical exams, blood and urine tests, electrocardiograms, photographs of the scalp, and questionnaires about their hair and quality of life. A small group of participants will also take part in interviews.  A final follow-up will occur one month after the treatment period ends.\n",
                  "total_sites": 2,
                  "similarity_score": 0.7710390376246231
                },
                {
                  "id": 85,
                  "trial_name": "A Phase 3 Randomized, Double-Blind, Placebo-Controlled, 78-Week Efficacy and Safety Study of VK2735 Administered Subcutaneously for Weight Management in Participants without Type 2 Diabetes who are Obese, or Overweight with at Least One Weight-related Comorbid Condition (VANQUISH-1)",
                  "conditions": "Obesity",
                  "description": "This is a Phase 3, randomized, double-blind, placebo-controlled, multi-center study sponsored by Viking Therapeutics Inc.  This means that some participants will receive VK2735 while others receive a placebo, and neither the participants nor the study staff will know who is receiving which.  The study will take place over approximately 88 weeks, including a screening period, 78 weeks of treatment, and a follow-up period. The study aims to evaluate the effectiveness and safety of VK2735 for weight loss.  The locations of the study sites are not specified in this protocol excerpt.\n\nThis study is for adults who are obese (BMI \u226530 kg/m\u00b2) or overweight (BMI \u226527 kg/m\u00b2) with at least one weight-related health issue, but who do *not* have Type 2 Diabetes.  You must be willing to attend regular study visits and follow the study procedures.  Women make up no more than 65% of the participants to ensure enough men are included. The study aims to include people from diverse ethnic and racial backgrounds and those over 65.  If you are eligible and choose to participate, you will be randomly assigned to receive either VK2735 or a placebo.  You will need to attend study visits regularly, especially in the first 33 weeks.\n\nParticipants will receive weekly injections of VK2735 or placebo under the skin. The dose of VK2735 will be gradually increased over several weeks until the target dose is reached.  The study will measure changes in body weight, BMI, waist circumference, blood pressure, cholesterol, and other health indicators.  The main goal is to see if VK2735 is better than placebo at helping people lose weight.  Other goals include assessing the percentage of participants achieving various levels of weight loss (e.g., 5%, 10%, 15%, 20%), and evaluating the impact of VK2735 on blood sugar, cholesterol levels, and quality of life.  Visits will be weekly for the first 33 weeks, then monthly, with self-administered injections between monthly visits.  You will also undergo regular blood tests, vital sign checks, and other assessments.",
                  "investigator_name": "Dr. Robert Springer",
                  "site_location": "Atlanta, GA",
                  "protocol_summary": "This is a Phase 3, randomized, double-blind, placebo-controlled, multi-center study sponsored by Viking Therapeutics Inc.  This means that some participants will receive VK2735 while others receive a placebo, and neither the participants nor the study staff will know who is receiving which.  The study will take place over approximately 88 weeks, including a screening period, 78 weeks of treatment, and a follow-up period. The study aims to evaluate the effectiveness and safety of VK2735 for weight loss.  The locations of the study sites are not specified in this protocol excerpt.\n\nThis study is for adults who are obese (BMI \u226530 kg/m\u00b2) or overweight (BMI \u226527 kg/m\u00b2) with at least one weight-related health issue, but who do *not* have Type 2 Diabetes.  You must be willing to attend regular study visits and follow the study procedures.  Women make up no more than 65% of the participants to ensure enough men are included. The study aims to include people from diverse ethnic and racial backgrounds and those over 65.  If you are eligible and choose to participate, you will be randomly assigned to receive either VK2735 or a placebo.  You will need to attend study visits regularly, especially in the first 33 weeks.\n\nParticipants will receive weekly injections of VK2735 or placebo under the skin. The dose of VK2735 will be gradually increased over several weeks until the target dose is reached.  The study will measure changes in body weight, BMI, waist circumference, blood pressure, cholesterol, and other health indicators.  The main goal is to see if VK2735 is better than placebo at helping people lose weight.  Other goals include assessing the percentage of participants achieving various levels of weight loss (e.g., 5%, 10%, 15%, 20%), and evaluating the impact of VK2735 on blood sugar, cholesterol levels, and quality of life.  Visits will be weekly for the first 33 weeks, then monthly, with self-administered injections between monthly visits.  You will also undergo regular blood tests, vital sign checks, and other assessments.",
                  "total_sites": 4,
                  "similarity_score": 0.7676449959903872
                }
              ],
              "semantic_search": true
            },
            "response_time": 20.336241960525513,
            "timestamp": "2025-12-16T07:31:18.182657"
          },
          {
            "user_message": "Yes, check my eligibility",
            "bot_response": "Great! I'll help you check your eligibility.\n\nI need to ask you a few questions about the diabetes trial.\n\n**Question 1 of 5:** What is your age?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "start_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": "yes",
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "start_prescreening",
                "parameters": {},
                "response_text": "Great! I can help with that. I'll ask a few questions to see if you might be a good fit for any of these studies. This is just a preliminary check, and it will help us narrow down the options.\n\nTo start, could you please tell me your age?",
                "new_state": "prescreening_started",
                "collect_entities": [
                  "age"
                ],
                "metadata": {
                  "reasoning": "The user has explicitly agreed to an eligibility check after being shown a list of trials (state: trials_shown). The most appropriate action is to initiate the prescreening process. The response confirms this action, sets expectations for the user, and asks the first common eligibility question (age) to begin. The state is updated to 'prescreening_started' to reflect this new phase of the conversation."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "prescreening_started": true,
              "trial_id": 86,
              "trial_name": "A Phase 3 Randomized, Double-Blind, Placebo-Controlled, 78-Week Efficacy and Safety Study of VK2735 Administered Subcutaneously for Weight Management in Participants with Type 2 Diabetes who are Obese, or Overweight (VANQUISH-2)",
              "current_question_index": 0,
              "total_questions": 5,
              "current_question": "What is your age?",
              "expected_answer_type": "number"
            },
            "response_time": 20.837229013442993,
            "timestamp": "2025-12-16T07:31:39.020156"
          },
          {
            "user_message": "65",
            "bot_response": "Got it.\n\nWhat is your current weight and height?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": 65,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {
                  "last_answer": {
                    "age": 65
                  }
                },
                "response_text": "Great, thanks for sharing that. Next question: How long have you been diagnosed with Type 2 Diabetes?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "duration"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and has just provided their age in response to a question. The logical next step is to acknowledge their answer and ask the next question in the prescreening sequence to continue determining their potential eligibility. The state remains 'prescreening_active' as the process is ongoing."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "current_question_index": 1,
              "total_questions": 5,
              "current_question": "What is your current weight and height?",
              "expected_answer_type": "text",
              "parsed_answer": {
                "interpretation": "number",
                "confidence": 1.0
              }
            },
            "response_time": 17.979424715042114,
            "timestamp": "2025-12-16T07:31:57.000184"
          },
          {
            "user_message": "5'1\"",
            "bot_response": "I found your height (5'1\") but couldn't determine your weight. Could you specify your weight?\n\nExamples: '180 pounds', '180 lbs', '215', or '82 kg'",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": "5'1\"",
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thanks for sharing. Next, could you please tell me your current weight?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and has just provided their height in response to a question. The correct action is to continue the prescreening process by asking the next logical question. In the context of a Type 2 Diabetes trial, asking for weight after height is a standard step, often to calculate BMI, which is a common eligibility criterion. The state remains 'prescreening_active' as the process is ongoing."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 15.185867071151733,
            "timestamp": "2025-12-16T07:32:12.186436"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Great, thank you. Could you please provide your current weight? This information is needed to check against the study's eligibility criteria.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session and has responded 'Yes' to a question that required both a confirmation and a specific piece of data (their weight). They have provided the confirmation but not the data. The correct action is to continue the prescreening by acknowledging their response and re-prompting for the missing information to move forward with the eligibility check. The state remains 'prescreening_active' as the process is not yet complete."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 22.423030853271484,
            "timestamp": "2025-12-16T07:32:34.610635"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Great. Could you please tell me your height and weight? This information is often used to calculate Body Mass Index (BMI), which is a common eligibility criterion for many studies.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session and has responded affirmatively ('Yes'), likely to a prompt asking if they are ready to provide more information or confirming a previous statement. The OpenAI reasoning indicates that height and weight information is the next required data point. Therefore, the best action is to continue the prescreening process by explicitly asking for the user's height and weight. Providing context about BMI makes the request more transparent and helpful. The state remains 'prescreening_active' as the process is ongoing."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 39.874836921691895,
            "timestamp": "2025-12-16T07:33:14.486441"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thanks for confirming. My apologies if my last question wasn't clear. To continue with the prescreener, could you please provide your current height and weight? This information is often used to calculate Body Mass Index (BMI), which is a common requirement for many studies.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and has responded with 'Yes'. This response does not provide the specific information likely requested in the previous turn (e.g., height and weight). The best course of action is to continue the prescreening process by gently re-prompting for the necessary information. The response clarifies what is needed and why, ensuring the user understands the next step while maintaining a supportive and helpful tone."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 20.834477186203003,
            "timestamp": "2025-12-16T07:33:35.321517"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Great! To move forward, could you please provide your height and weight? This information helps us check some of the basic eligibility criteria.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and responded with a simple 'Yes', likely to a question requiring specific information (e.g., height and weight). This action acknowledges their affirmative response and gently re-prompts for the necessary details to continue the eligibility check, keeping the conversation on track and maintaining a supportive tone. The state remains 'prescreening_active' as we are still on the same step."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 24.04652738571167,
            "timestamp": "2025-12-16T07:33:59.368420"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Great, thanks for confirming. To continue with the next step, I'll also need your height and weight. This is often used to calculate Body Mass Index (BMI) for the study's requirements. Could you please provide that information?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session and has confirmed a previous question with 'Yes' but did not provide the necessary follow-up information (height and weight, as inferred from the OpenAI reasoning). The best action is to continue the prescreening by gently re-prompting for the specific missing data. This acknowledges their response, explains the need for the information, and keeps the conversation moving forward within the same state."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 55.60342597961426,
            "timestamp": "2025-12-16T07:34:54.972251"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thanks for confirming. To move forward, could you please provide your height and weight? This information is often used to calculate BMI, which is a common requirement for many studies.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and responded with a simple 'Yes', which does not answer the likely previous question about specific information like height and weight. The most appropriate action is to continue the prescreening process by gently re-prompting for the required information. The response clarifies what is needed (height and weight) and explains why (for BMI calculation), which is helpful and transparent. The state remains 'prescreening_active' because we are still trying to collect the same piece of eligibility information."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 54.07056498527527,
            "timestamp": "2025-12-16T07:35:49.044344"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Great! To check some of the eligibility criteria, I'll need to calculate your Body Mass Index (BMI). Could you please tell me your current height and weight?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in the 'prescreening_active' state and has provided an affirmative 'Yes', likely agreeing to continue with the eligibility questions. The conversation history and reasoning suggest that height and weight are the next required pieces of information, often used to calculate BMI for trial eligibility. The chosen action is 'continue_prescreening' to ask for this specific information, keeping the user engaged and moving them forward in the process. The response is helpful by explaining why the information is needed (for BMI calculation)."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 24.67605996131897,
            "timestamp": "2025-12-16T07:36:13.720789"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Great! To move forward with the eligibility check, I'll just need your current height and weight. Could you please provide that?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and responded with 'Yes'. Based on the provided reasoning, the previous turn likely asked for height and weight, which this response does not provide. The best action is to continue the prescreening by gently re-prompting for the necessary information. The response acknowledges their affirmative input and then clearly restates the required information, keeping the conversation on track in a friendly manner. The state remains 'prescreening_active' as we are still on the same step."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 23.986816883087158,
            "timestamp": "2025-12-16T07:36:37.707918"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thanks for your response. To continue with the eligibility check, I'll need a bit more specific information. The next question is about your height and weight, which helps determine if you meet criteria like Body Mass Index (BMI). Could you please provide that for me?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and provided a 'Yes' answer. The context suggests the previous question required specific information (like height and weight), not a boolean response. The best action is to continue the prescreening by gently clarifying the needed information and re-asking the question to get the process back on track. The state remains 'prescreening_active' as we are still in the middle of the eligibility check."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 40.672773122787476,
            "timestamp": "2025-12-16T07:37:18.380995"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "My apologies, I should have been more specific. To continue with the screening, I'll need your actual height and weight. Could you please provide them? For example, you can write '5'10\", 180 lbs'.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and provided a 'Yes' response, which is not a valid answer to the likely previous question about height and weight. The best action is to continue the prescreening by politely re-prompting for the required information in the correct format, explaining why it's needed, and providing an example to guide the user. The state remains 'prescreening_active' as we are re-asking the current question."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 24.993831157684326,
            "timestamp": "2025-12-16T07:37:43.375772"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Great! To continue, could you please tell me your height and weight? This information is often used to calculate Body Mass Index (BMI), which is a common eligibility criterion for these types of studies.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and has responded with 'Yes'. The previous turn likely asked for specific information, not a yes/no question. The user's response indicates a willingness to proceed. The best action is to gently re-ask the question to gather the necessary information (height and weight) to continue the eligibility check, while explaining why it's needed. The state remains 'prescreening_active' as we are still in the middle of the process."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 20.583789110183716,
            "timestamp": "2025-12-16T07:38:03.961322"
          },
          {
            "user_message": "Yes",
            "bot_response": "I'm here to help you find clinical trials. What condition are you interested in?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "general_response",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "general_response",
                "parameters": {},
                "response_text": "I'm here to help you find clinical trials. What condition are you interested in?",
                "new_state": "initial",
                "collect_entities": null,
                "metadata": {
                  "fallback": true
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "general_response": true
            },
            "response_time": 50.39823508262634,
            "timestamp": "2025-12-16T07:38:54.359746"
          },
          {
            "user_message": "Yes, I have Type 2 Diabetes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": "Type 2 Diabetes",
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": "yes",
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {
                  "answer": "Yes, I have Type 2 Diabetes"
                },
                "response_text": "Okay, thank you for confirming. The next question is about your age. Could you please tell me how old you are?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "age"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session and has just answered a question confirming their condition. The correct action is to acknowledge their answer and proceed with the next question in the prescreening sequence to continue assessing their eligibility. Asking for age is a standard and logical next step in this process, as it is a common eligibility criterion."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 22.771705150604248,
            "timestamp": "2025-12-16T07:39:17.131947"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {
                  "next_question": "ask_bmi_components"
                },
                "response_text": "I appreciate the confirmation! To move forward with the prescreening, could you please tell me your current height and weight? This information is needed to see if you meet the study's BMI criteria.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session. Their response 'Yes' did not answer the previous question, which required their height and weight. The best action is to continue the prescreening by gently re-prompting for the necessary information, explaining why it's needed to help guide the user. The state remains 'prescreening_active' as we have not yet collected the required data to advance."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 21.97435188293457,
            "timestamp": "2025-12-16T07:39:39.107384"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thanks for confirming. To continue with the next step, could you please tell me your current height and weight? This is often used to calculate BMI for the study's requirements.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and provided a non-specific affirmative answer ('Yes') to a question that required specific information (height and weight). The best action is to continue the prescreening by gently re-prompting for the required information. This response acknowledges their input, clarifies what is needed next, and explains the reason for the question to build trust and keep the user engaged. The state remains 'prescreening_active' as the process is ongoing."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 28.03034996986389,
            "timestamp": "2025-12-16T07:40:07.140026"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thanks for confirming. To continue with the next step, could you please tell me your height and weight? This helps us calculate your BMI, which is a common eligibility requirement for many studies.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and has responded with a simple 'Yes', which does not answer the previous, more specific question (inferred to be about height and weight). The best course of action is to continue the prescreening process by gently re-prompting for the necessary information. The response clarifies why this information is needed (for BMI calculation), which is helpful and transparent, encouraging the user to provide the details to move forward."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 24.390825986862183,
            "timestamp": "2025-12-16T07:40:31.531453"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thanks for confirming. To continue with the eligibility check, could you please provide your height and weight? This information is often used to calculate Body Mass Index (BMI), which is a common requirement for many Type 2 Diabetes studies.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state but provided a 'Yes' which does not answer the previous question (which, based on the provided reasoning, was for height and weight). The best action is to continue the prescreening by gently re-prompting for the required information. Explaining why it's needed (for BMI calculation) adds context and helps guide the user back on track. The state remains 'prescreening_active' as we are still on the same step of the process."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 24.652008295059204,
            "timestamp": "2025-12-16T07:40:56.183836"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Great! To move forward, could you please provide your height and weight? This is often used to calculate Body Mass Index (BMI), a common factor in trial eligibility.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and responded with 'Yes', which doesn't answer the previous question that likely asked for their height and weight (based on the provided reasoning). The best action is to continue the prescreening by gently re-prompting for the required information. Providing context on why this information is needed (for BMI calculation) is helpful and transparent, guiding the user to the next step."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 19.600144147872925,
            "timestamp": "2025-12-16T07:41:15.784699"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thanks for confirming. To continue with the prescreening, I'll need your height and weight. This helps determine if you meet the study's BMI requirements. Could you please provide that information?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and has provided a 'Yes' response, which is not a valid answer to the previous question that required their height and weight. The chosen action is 'continue_prescreening' to handle this invalid input. The response gently re-prompts the user for the necessary information, explains why it's needed (for BMI calculation), and keeps the conversation moving forward within the prescreening flow. The state remains 'prescreening_active' as we are still attempting to collect the same information."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 23.577724933624268,
            "timestamp": "2025-12-16T07:41:39.363222"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {
                  "next_question": "height_and_weight"
                },
                "response_text": "Great. Could you please tell me your height and weight? We use this to calculate your Body Mass Index (BMI), which is a common eligibility criterion for many studies.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and has affirmed their willingness to answer the next question by saying 'Yes', but did not provide the specific information (height and weight) that was likely requested. The best action is to continue the prescreening flow by explicitly prompting for the missing height and weight. This keeps the user engaged and moves them closer to completing the eligibility check."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 23.64668917655945,
            "timestamp": "2025-12-16T07:42:03.011033"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "My apologies, I think I may have been unclear. To move forward with the eligibility check, I'll need your current height and weight. Could you please provide that information?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and has provided a boolean 'Yes' answer, which is not a valid response to the likely previous question asking for height and weight. The best action is to continue the prescreening by gently re-prompting for the required information. This clarifies what is needed from the user and keeps the conversation on track towards their goal of checking eligibility, while maintaining a helpful and supportive tone."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 21.34251594543457,
            "timestamp": "2025-12-16T07:42:24.354128"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thanks for confirming. To continue with the eligibility check, could you please tell me your height and weight? This information helps us see if you meet the study's specific requirements.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and provided a 'Yes' response, which is not a valid answer to the previous question asking for height and weight. The chosen action is to continue the prescreening by gently re-asking the question. The response is designed to be polite and clarifying, explaining why the information is needed to guide the user back on track without making them feel they made an error. The state remains 'prescreening_active' as the goal is to complete the current questionnaire."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 21.918487071990967,
            "timestamp": "2025-12-16T07:42:46.273189"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Great! To move forward, could you please tell me your height and weight? This information is often used to calculate Body Mass Index (BMI) for the study's requirements.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session and responded with a simple 'Yes', which did not provide the specific information needed to proceed (likely height and weight, based on the context of a BMI calculation). The chosen action is 'continue_prescreening' to re-prompt for the necessary data. The response is crafted to be encouraging, clearly restates the required information, and provides a helpful explanation for why it's needed (for BMI), guiding the user to the next step without causing frustration."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 23.128262281417847,
            "timestamp": "2025-12-16T07:43:09.401955"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "I appreciate your willingness to continue! To move forward, I'll need a bit more specific information. Could you please tell me your height and weight? This is a common requirement for many studies.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and provided a 'Yes' response, which is not a valid answer to the likely previous question (e.g., asking for height and weight). The best action is to continue the prescreening by gently re-asking the question, clarifying the type of information needed, and maintaining a supportive tone to keep the user engaged in the process. The state remains 'prescreening_active' as we are still in the middle of the eligibility check."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 20.386959075927734,
            "timestamp": "2025-12-16T07:43:29.789525"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thanks for confirming. To continue with the next step, could you please tell me your current height and weight? This is often used to determine Body Mass Index (BMI), a common factor in trial eligibility.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and responded with 'Yes'. Based on the context, the previous question likely required specific information (like height and weight), not a yes/no answer. The best action is to continue the prescreening by gently re-asking the question to get the necessary details and keep the process moving forward accurately. The response explains why the information is needed, which is helpful and transparent."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 24.11922287940979,
            "timestamp": "2025-12-16T07:43:53.909381"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "My apologies if my last question wasn't clear. To continue with the eligibility check for this trial, I'll need your current height and weight. Could you please provide that information?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and responded with 'Yes'. However, the previous question likely required specific information (height and weight), not a yes/no answer. The best action is to continue the prescreening process by gently re-prompting for the necessary details. This response clarifies what is needed, explains why, and maintains a supportive tone to keep the user engaged and get the process back on track."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 24.27525305747986,
            "timestamp": "2025-12-16T07:44:18.185523"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thanks for confirming. To make sure we're checking all the boxes for this study, I'll need your height and weight. This is often used to calculate BMI, which is a common eligibility factor. Could you please share that with me when you're ready?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and provided a low-information 'Yes' response, which doesn't answer the likely previous question about height and weight. The best action is to continue the prescreening by gently re-prompting for the necessary information. Explaining that this is for a BMI calculation adds helpful context and maintains a supportive tone. The state remains 'prescreening_active' as we are still waiting for the answer to the current question."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 24.478443145751953,
            "timestamp": "2025-12-16T07:44:42.665671"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_diabetes_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "My apologies if my last question wasn't clear. To continue with the eligibility check for this trial, could you please tell me your height and weight? This information helps determine if you meet the study's specific requirements.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session and provided a 'Yes' response, which does not answer the previous question about their height and weight. The appropriate action is to continue the prescreening by gently re-prompting for the necessary information. The response is crafted to be polite and clarifying, guiding the user back on track without making them feel they made a mistake. The state remains 'prescreening_active' as the process is ongoing."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 23.42979907989502,
            "timestamp": "2025-12-16T07:45:06.098841"
          }
        ],
        "final_state": "completed",
        "total_turns": 32,
        "total_questions_asked": 5,
        "errors": [
          {
            "type": "too_many_turns",
            "turns_processed": 30
          }
        ]
      },
      "validation": {
        "passed": false,
        "overall_score": 50.0,
        "crash_prevention": {
          "passed": true,
          "score": 100.0,
          "error_count": 0,
          "errors": [],
          "failures": []
        },
        "eligibility_accuracy": {
          "passed": false,
          "score": 0.0,
          "reason": "Could not extract eligibility result",
          "failures": [
            {
              "type": "eligibility_logic_error",
              "reason": "No eligibility determination found in conversation",
              "likely_location": "core/prescreening/gemini_prescreening_manager.py:evaluate_eligibility()",
              "severity": "high"
            }
          ]
        },
        "conversation_quality": {
          "passed": false,
          "score": 0.0,
          "total_questions_asked": 5,
          "issues": [
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y..."
          ],
          "failures": [
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            }
          ]
        },
        "edge_case_handling": {
          "passed": true,
          "score": 100.0,
          "applicable": false,
          "failures": []
        },
        "performance": {
          "passed": false,
          "score": 40.0,
          "avg_response_time": 26.507058545947075,
          "max_response_time": 55.60342597961426,
          "status": "slow",
          "failures": [
            {
              "type": "performance_issue",
              "avg_response_time": 26.507058545947075,
              "max_response_time": 55.60342597961426,
              "severity": "low",
              "recommendation": "Investigate slow API responses or Gemini API delays"
            }
          ]
        },
        "failure_points": [
          {
            "type": "eligibility_logic_error",
            "reason": "No eligibility determination found in conversation",
            "likely_location": "core/prescreening/gemini_prescreening_manager.py:evaluate_eligibility()",
            "severity": "high"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "performance_issue",
            "avg_response_time": 26.507058545947075,
            "max_response_time": 55.60342597961426,
            "severity": "low",
            "recommendation": "Investigate slow API responses or Gemini API delays"
          }
        ],
        "recommendations": [
          "\u26a0\ufe0f HIGH: Review eligibility evaluation logic in gemini_prescreening_manager.py",
          "\u26a0\ufe0f MEDIUM: Major conversation quality issues. Review question generation and response handling.",
          "\u2139\ufe0f LOW: Slow response times. Optimize API calls or consider caching."
        ]
      },
      "timestamp": "2025-12-16T07:45:06.100079"
    },
    {
      "patient_id": "AUTO_TEST_random_001",
      "patient_profile": {
        "patient_id": "AUTO_TEST_random_001",
        "profile_type": "random",
        "demographics": {
          "age": 59,
          "gender": "non-binary",
          "location": "Baton Rouge, LA",
          "name": "Mary Jones",
          "first_name": "Mary",
          "last_name": "Jones"
        },
        "medical_history": {
          "primary_condition": "Hidradenitis Suppurativa",
          "conditions": [
            "Hidradenitis Suppurativa"
          ],
          "medications": [
            "Antibiotics",
            "Adalimumab",
            "Humira"
          ],
          "duration_years": 7
        },
        "expected_behavior": {
          "should_find_trials": true,
          "likely_eligible": true,
          "expected_question_count_range": [
            4,
            8
          ]
        }
      },
      "conversation_result": {
        "session_id": "AUTO_TEST_random_001",
        "patient_id": "AUTO_TEST_random_001",
        "conversation_log": [
          {
            "user_message": "Hidradenitis Suppurativa trials in Baton Rouge, LA",
            "bot_response": "Great! I found 5 clinical trial(s) available in Baton Rouge:\n\n**Dr. Ira Thorla**\n  \u2022 Hidradenitis Suppurativa (3 trials)\n  \u2022 Female Pattern Hair Loss (Androgenetic Alopecia) (1 trial)\n  \u2022 Acne Vulgaris (1 trial)\n\nWould you like to:\n1. Check your eligibility for any of these trials?\n2. Learn more about a specific condition?\n3. See trials in a different location?",
            "metadata": {
              "session_id": "AUTO_TEST_random_001",
              "current_state": "trials_shown",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "search_trials",
              "entities_collected": {
                "condition": "Hidradenitis Suppurativa",
                "location": "Baton Rouge",
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "search_trials",
                "parameters": {
                  "condition": "Hidradenitis Suppurativa",
                  "location": "Baton Rouge"
                },
                "response_text": "Of course, we can definitely switch gears. I'll search for clinical trials for Hidradenitis Suppurativa in the Baton Rouge, LA area now. One moment while I look that up for you.",
                "new_state": "trial_results_ready",
                "collect_entities": [],
                "metadata": {
                  "reasoning": "The user has provided a new condition and location, indicating a clear context switch from the previous prescreening for Bipolar Depression. The most helpful action is to fulfill this new, explicit request by searching for trials with the provided information. This acknowledges their new goal and moves the conversation forward efficiently. The state is updated to reflect that a new search has been initiated."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "trials_found": 5,
              "condition": "Hidradenitis Suppurativa",
              "location": "Baton Rouge",
              "trials_data": [
                {
                  "id": 80,
                  "trial_name": "A Maximal Use Trial of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa",
                  "conditions": "Hidradenitis Suppurativa",
                  "description": "This is a Phase 1, open-label (not blinded), single-group study sponsored by Incyte Corporation.  The study will be conducted at multiple locations (multicenter) and is designed to evaluate the safety and tolerability of ruxolitinib cream. The total study duration, including screening, treatment, and follow-up, could be up to approximately 24 weeks.\n\nThis study is for adults and adolescents aged 12 to 75 years who have been diagnosed with hidradenitis suppurativa (HS) for at least 6 months.  To be eligible, you must have at least 4 abscesses and inflammatory nodules affecting at least 3 different areas of your body, with a total treatment area greater than 20% of your body surface area.  You may not be eligible if you have certain other skin conditions or are taking specific medications. During the study, you will be asked to apply the study cream twice daily to all affected areas and attend regular visits for check-ups and assessments.\n\nIn this study, you will apply ruxolitinib 1.5% cream twice daily to all affected areas for 4 weeks.  Researchers will monitor your health through blood tests, physical exams, and by asking you about any side effects.  The main goals are to assess the safety and tolerability of the cream, including any side effects, and to measure how much of the drug gets into your bloodstream.  Secondary goals include evaluating the cream's effect on your HS lesions, pain, itching, and quality of life.  You will have regular visits during the 4-week treatment period and potentially for a longer extension period, followed by a final safety follow-up visit.",
                  "investigator_name": "Dr. Ira Thorla",
                  "site_location": "Baton Rouge, LA",
                  "protocol_summary": "This is a Phase 1, open-label (not blinded), single-group study sponsored by Incyte Corporation.  The study will be conducted at multiple locations (multicenter) and is designed to evaluate the safety and tolerability of ruxolitinib cream. The total study duration, including screening, treatment, and follow-up, could be up to approximately 24 weeks.\n\nThis study is for adults and adolescents aged 12 to 75 years who have been diagnosed with hidradenitis suppurativa (HS) for at least 6 months.  To be eligible, you must have at least 4 abscesses and inflammatory nodules affecting at least 3 different areas of your body, with a total treatment area greater than 20% of your body surface area.  You may not be eligible if you have certain other skin conditions or are taking specific medications. During the study, you will be asked to apply the study cream twice daily to all affected areas and attend regular visits for check-ups and assessments.\n\nIn this study, you will apply ruxolitinib 1.5% cream twice daily to all affected areas for 4 weeks.  Researchers will monitor your health through blood tests, physical exams, and by asking you about any side effects.  The main goals are to assess the safety and tolerability of the cream, including any side effects, and to measure how much of the drug gets into your bloodstream.  Secondary goals include evaluating the cream's effect on your HS lesions, pain, itching, and quality of life.  You will have regular visits during the 4-week treatment period and potentially for a longer extension period, followed by a final safety follow-up visit.",
                  "total_sites": 1,
                  "similarity_score": 0.8163552408254671
                },
                {
                  "id": 51,
                  "trial_name": "A Phase 2, Multi-Center Study Consisting of a Randomized, Placebo-Controlled Period, Followed by an Open-Label Extension Period to Assess the Efficacy, Safety, and Tolerability of Tibulizumab in Adults with Hidradenitis Suppurativa",
                  "conditions": "Hidradenitis Suppurativa",
                  "description": "This is a Phase 2 research study, meaning it's one of the early stages of testing a new drug called tibulizumab.  The study is randomized, which means participants are assigned to different treatment groups by chance, like flipping a coin.  It's also placebo-controlled and double-blind, meaning some participants will receive a placebo (an inactive substance) and neither the participants nor the researchers will know who is getting which treatment until the end of the study.  This helps ensure the results are accurate. The study is sponsored by Zura Bio Inc. and will be conducted at approximately 53 sites across the United States, Canada, and Europe.  The maximum time a participant will be in the study is about 44 weeks.\n\nThis study is looking for adults with moderate to severe hidradenitis suppurativa (HS). To be eligible, you must have HS lesions in at least two different areas of your body, with at least one area being Hurley Stage II or III, and a total abscess and inflammatory nodule count of 5 or more.  You won't be able to participate if you have more than 20 draining fistulas.  Up to 30% of participants may have previously used anti-TNF\u03b1 therapies, and up to 40% may have Hurley Stage III HS.  During the study, you'll receive injections and attend regular check-ups at the study site.  Your participation will involve several visits over approximately 44 weeks, including a screening period, a treatment period, and a follow-up period.\n\nIn this study, you'll receive either tibulizumab (150mg or 300mg) or a placebo by subcutaneous injection (under the skin) every 4 weeks, with an extra dose at week 2.  Researchers will be tracking the number of your HS lesions, how your HS affects your quality of life (using questionnaires like the DLQI and HS-PtGA), and any pain you experience.  The main goal is to see how much tibulizumab reduces the number of abscesses and inflammatory nodules.  They'll also be checking your overall health through blood tests and other assessments.  You'll need to visit the study center approximately 13 times throughout the study, including a screening visit, treatment visits, and a final follow-up visit.",
                  "investigator_name": "Dr. Ira Thorla",
                  "site_location": "Baton Rouge, LA",
                  "protocol_summary": "This is a Phase 2 research study, meaning it's one of the early stages of testing a new drug called tibulizumab.  The study is randomized, which means participants are assigned to different treatment groups by chance, like flipping a coin.  It's also placebo-controlled and double-blind, meaning some participants will receive a placebo (an inactive substance) and neither the participants nor the researchers will know who is getting which treatment until the end of the study.  This helps ensure the results are accurate. The study is sponsored by Zura Bio Inc. and will be conducted at approximately 53 sites across the United States, Canada, and Europe.  The maximum time a participant will be in the study is about 44 weeks.\n\nThis study is looking for adults with moderate to severe hidradenitis suppurativa (HS). To be eligible, you must have HS lesions in at least two different areas of your body, with at least one area being Hurley Stage II or III, and a total abscess and inflammatory nodule count of 5 or more.  You won't be able to participate if you have more than 20 draining fistulas.  Up to 30% of participants may have previously used anti-TNF\u03b1 therapies, and up to 40% may have Hurley Stage III HS.  During the study, you'll receive injections and attend regular check-ups at the study site.  Your participation will involve several visits over approximately 44 weeks, including a screening period, a treatment period, and a follow-up period.\n\nIn this study, you'll receive either tibulizumab (150mg or 300mg) or a placebo by subcutaneous injection (under the skin) every 4 weeks, with an extra dose at week 2.  Researchers will be tracking the number of your HS lesions, how your HS affects your quality of life (using questionnaires like the DLQI and HS-PtGA), and any pain you experience.  The main goal is to see how much tibulizumab reduces the number of abscesses and inflammatory nodules.  They'll also be checking your overall health through blood tests and other assessments.  You'll need to visit the study center approximately 13 times throughout the study, including a screening visit, treatment visits, and a final follow-up visit.",
                  "total_sites": 3,
                  "similarity_score": 0.789239772908223
                },
                {
                  "id": 14,
                  "trial_name": "Clinical Trial 250-13951-306",
                  "conditions": "Female Pattern Hair Loss (Androgenetic Alopecia)",
                  "description": null,
                  "investigator_name": "Dr. Ira Thorla",
                  "site_location": "Baton Rouge, LA",
                  "protocol_summary": "This clinical trial aims to investigate the effectiveness and safety of an oral medication called VDPHL01 for treating female pattern hair loss (androgenetic alopecia).  The study will evaluate two different dosing regimens of VDPHL01: twice daily and once daily.  It will compare these regimens against a placebo to see if the medication promotes hair growth and improves patient satisfaction with their hair.\n\nWomen aged 18-65 with mild to moderate hair loss, as measured by the Savin Scale, are eligible to participate.  Key inclusion criteria include good general health, adequate kidney and liver function, and a commitment to maintaining consistent hair care routines throughout the study.  Women who are pregnant, breastfeeding, have certain medical conditions (like uncontrolled blood pressure or a history of heart problems), or have recently used other hair growth treatments are excluded.\n\nThe study will last approximately 13 months and consist of two parts. Part A is a 6-month placebo-controlled period, where participants are randomly assigned to one of four groups: VDPHL01 twice daily, VDPHL01 once daily plus placebo, placebo twice daily, or placebo twice daily.  Part B is a 6-month treatment extension, where those initially receiving placebo will start taking VDPHL01 according to their initial group assignment, while those already on VDPHL01 will continue.  Participants will have regular clinic visits (approximately 11) for assessments including physical exams, blood and urine tests, electrocardiograms, photographs of the scalp, and questionnaires about their hair and quality of life. A small group of participants will also take part in interviews.  A final follow-up will occur one month after the treatment period ends.\n",
                  "total_sites": 2,
                  "similarity_score": 0.7864790864830788
                }
              ],
              "semantic_search": true
            },
            "response_time": 24.365938901901245,
            "timestamp": "2025-12-16T07:31:22.216942"
          },
          {
            "user_message": "Yes, check my eligibility",
            "bot_response": "Great! I'll help you check your eligibility.\n\nI need to ask you a few questions about the hidradenitis suppurativa trial.\n\n**Question 1 of 6:** What is your age?",
            "metadata": {
              "session_id": "AUTO_TEST_random_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "start_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": "yes",
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "start_prescreening",
                "parameters": {},
                "response_text": "Great, I can help with that. I'll ask you a few questions based on the common eligibility criteria for these Hidradenitis Suppurativa trials to see if they might be a good fit.\n\nTo start, could you please tell me your age?",
                "new_state": "prescreening_started",
                "collect_entities": [
                  "age"
                ],
                "metadata": {
                  "reasoning": "The user has explicitly confirmed their interest in checking eligibility for the trials that were just presented (current state is 'trials_shown'). The correct action is to initiate the prescreening process. The response confirms their request, sets the expectation that a few questions will be asked, and then asks the first common eligibility question (age) to begin. The state is transitioned to 'prescreening_started' to reflect this new phase of the conversation."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "prescreening_started": true,
              "trial_id": 80,
              "trial_name": "A Maximal Use Trial of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa",
              "current_question_index": 0,
              "total_questions": 6,
              "current_question": "What is your age?",
              "expected_answer_type": "number"
            },
            "response_time": 18.21587896347046,
            "timestamp": "2025-12-16T07:31:40.433162"
          },
          {
            "user_message": "59",
            "bot_response": "Got it.\n\nHave you been diagnosed with hs for \u2265 6 months by a doctor?",
            "metadata": {
              "session_id": "AUTO_TEST_random_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": 59,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {
                  "question_id": "hs_lesion_count"
                },
                "response_text": "Thanks for sharing that. The next question is about your symptoms. In the last month, have you had a total of 5 or more abscesses and inflammatory nodules combined? This count should include all affected areas of your body.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "boolean_answer"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening flow and has provided their age in response to a direct question. The correct action is to acknowledge their answer and proceed with the next question in the prescreening sequence to continue assessing their eligibility. The next logical question for a Hidradenitis Suppurativa trial often relates to disease severity, such as the count of inflammatory lesions. The state remains 'prescreening_active' as the process is ongoing."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "current_question_index": 1,
              "total_questions": 6,
              "current_question": "Have you been diagnosed with hs for \u2265 6 months by a doctor?",
              "expected_answer_type": "yes_no",
              "parsed_answer": {
                "interpretation": "number",
                "confidence": 1.0
              }
            },
            "response_time": 17.823144912719727,
            "timestamp": "2025-12-16T07:31:58.256686"
          },
          {
            "user_message": "Yes, I have Hidradenitis Suppurativa",
            "bot_response": "Thank you.\n\nDo you meet the medical requirements needed to participate in this study?",
            "metadata": {
              "session_id": "AUTO_TEST_random_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": "Hidradenitis Suppurativa",
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Okay, thank you for confirming that. The next question is: Are you 18 years of age or older?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "boolean_answer",
                  "age"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session and has just answered the previous question, confirming their condition. The correct action is to continue with the next question in the prescreening flow to determine their eligibility. A question about age is a standard and logical next step in almost any clinical trial prescreener."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "current_question_index": 2,
              "total_questions": 6,
              "current_question": "Do you meet the medical requirements needed to participate in this study?",
              "expected_answer_type": "yes_no",
              "parsed_answer": {
                "interpretation": "yes",
                "confidence": 1.0
              }
            },
            "response_time": 28.634037971496582,
            "timestamp": "2025-12-16T07:32:26.891376"
          },
          {
            "user_message": "Yes, I believe I do",
            "bot_response": "Thank you.\n\nDo you have any known allergies to medications used in this study?",
            "metadata": {
              "session_id": "AUTO_TEST_random_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Okay, thank you for confirming. The next question is: Are you currently taking any biologic medications, such as Humira or Cosentyx, for your Hidradenitis Suppurativa?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "boolean_answer",
                  "medication"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session (`prescreening_active` state) and has just answered the previous question affirmatively. The logical next step is to continue the prescreening process by asking the next eligibility question. The response acknowledges their answer and poses the next relevant question to determine their potential match for the trial, keeping the conversation moving forward efficiently."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "current_question_index": 3,
              "total_questions": 6,
              "current_question": "Do you have any known allergies to medications used in this study?",
              "expected_answer_type": "yes_no",
              "parsed_answer": {
                "interpretation": "yes",
                "confidence": 1.0
              }
            },
            "response_time": 25.41403818130493,
            "timestamp": "2025-12-16T07:32:52.305968"
          },
          {
            "user_message": "Yes - Antibiotics, Adalimumab, Humira",
            "bot_response": "Thank you.\n\nHave you had any significant medical events in the past 7 days?",
            "metadata": {
              "session_id": "AUTO_TEST_random_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": [
                  "Antibiotics",
                  "Adalimumab",
                  "Humira"
                ],
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thank you for providing that information. It's really helpful to understand your treatment history. We just have a few more questions. How long ago were you diagnosed with Hidradenitis Suppurativa?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "duration"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and has just answered a question about their medication history. The most logical and helpful next step is to acknowledge their answer and proceed with the next question in the prescreening sequence. Asking about the duration of their diagnosis is a common and relevant question in this context. The state remains 'prescreening_active' as the process is ongoing."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "current_question_index": 4,
              "total_questions": 6,
              "current_question": "Have you had any significant medical events in the past 7 days?",
              "expected_answer_type": "yes_no",
              "parsed_answer": {
                "interpretation": "yes",
                "confidence": 1.0
              }
            },
            "response_time": 25.644847869873047,
            "timestamp": "2025-12-16T07:33:17.951354"
          },
          {
            "user_message": "I'm not sure, can you clarify?",
            "bot_response": "I'm here to help you find clinical trials. What condition are you interested in?",
            "metadata": {
              "session_id": "AUTO_TEST_random_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "general_response",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "general_response",
                "parameters": {},
                "response_text": "I'm here to help you find clinical trials. What condition are you interested in?",
                "new_state": "initial",
                "collect_entities": null,
                "metadata": {
                  "fallback": true
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "general_response": true
            },
            "response_time": 57.419310092926025,
            "timestamp": "2025-12-16T07:34:15.371030"
          },
          {
            "user_message": "Yes, I have Hidradenitis Suppurativa",
            "bot_response": "Thank you.\n\nHave you had any significant medical events in the past 30 days?",
            "metadata": {
              "session_id": "AUTO_TEST_random_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": "Hidradenitis Suppurativa",
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thank you for confirming. It's really helpful to have that information. Let's continue with the eligibility questions to see if this trial is a good fit for you. The next question is: Are you over 18 years of age?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "age",
                  "boolean_answer"
                ],
                "metadata": {
                  "reasoning": "The user has confirmed their condition, which was likely a clarifying question asked during an active prescreening session. The current state is 'prescreening_active', and the user's goal is to check their eligibility. Therefore, the most appropriate action is to continue the prescreening process. The response acknowledges their confirmation, provides a smooth transition back to the questionnaire, and asks the next logical eligibility question (age), which is a common and crucial criterion."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "current_question_index": 5,
              "total_questions": 6,
              "current_question": "Have you had any significant medical events in the past 30 days?",
              "expected_answer_type": "yes_no",
              "parsed_answer": {
                "interpretation": "yes",
                "confidence": 1.0
              }
            },
            "response_time": 51.172780990600586,
            "timestamp": "2025-12-16T07:35:06.545583"
          },
          {
            "user_message": "I'm not sure, can you clarify?",
            "bot_response": "I'm here to help you find clinical trials. What condition are you interested in?",
            "metadata": {
              "session_id": "AUTO_TEST_random_001",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "general_response",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "general_response",
                "parameters": {},
                "response_text": "I'm here to help you find clinical trials. What condition are you interested in?",
                "new_state": "initial",
                "collect_entities": null,
                "metadata": {
                  "fallback": true
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "general_response": true
            },
            "response_time": 57.816179037094116,
            "timestamp": "2025-12-16T07:36:04.362049"
          },
          {
            "user_message": "Yes, I have Hidradenitis Suppurativa",
            "bot_response": "Great! I found 5 clinical trial(s) available in Baton Rouge:\n\n**Dr. Ira Thorla**\n  \u2022 Hidradenitis Suppurativa (3 trials)\n  \u2022 Female Pattern Hair Loss (Androgenetic Alopecia) (1 trial)\n  \u2022 Acne Vulgaris (1 trial)\n\nWould you like to:\n1. Check your eligibility for any of these trials?\n2. Learn more about a specific condition?\n3. See trials in a different location?",
            "metadata": {
              "session_id": "AUTO_TEST_random_001",
              "current_state": "trials_shown",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "search_trials",
              "entities_collected": {
                "condition": "Hidradenitis Suppurativa",
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": "Yes",
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "search_trials",
                "parameters": {
                  "condition": "Hidradenitis Suppurativa",
                  "location": "Baton Rouge"
                },
                "response_text": "Thank you for confirming. I understand that Hidradenitis Suppurativa can be a challenging condition to manage. Now that I have your condition and location, I'll search for relevant clinical trials near Baton Rouge for you. Please give me just a moment.",
                "new_state": "trial_search_results",
                "collect_entities": [],
                "metadata": {
                  "reasoning": "The user has confirmed their condition, and the conversation context indicates we already have their location (Baton Rouge). With both the necessary pieces of information (condition and location), the next logical action is to search for relevant clinical trials. The response acknowledges the user's input, shows empathy, and clearly states the next step, which is to perform the search. The state is updated to reflect that the next turn will involve presenting these results."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "trials_found": 5,
              "condition": "Hidradenitis Suppurativa",
              "location": "Baton Rouge",
              "trials_data": [
                {
                  "id": 80,
                  "trial_name": "A Maximal Use Trial of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa",
                  "conditions": "Hidradenitis Suppurativa",
                  "description": "This is a Phase 1, open-label (not blinded), single-group study sponsored by Incyte Corporation.  The study will be conducted at multiple locations (multicenter) and is designed to evaluate the safety and tolerability of ruxolitinib cream. The total study duration, including screening, treatment, and follow-up, could be up to approximately 24 weeks.\n\nThis study is for adults and adolescents aged 12 to 75 years who have been diagnosed with hidradenitis suppurativa (HS) for at least 6 months.  To be eligible, you must have at least 4 abscesses and inflammatory nodules affecting at least 3 different areas of your body, with a total treatment area greater than 20% of your body surface area.  You may not be eligible if you have certain other skin conditions or are taking specific medications. During the study, you will be asked to apply the study cream twice daily to all affected areas and attend regular visits for check-ups and assessments.\n\nIn this study, you will apply ruxolitinib 1.5% cream twice daily to all affected areas for 4 weeks.  Researchers will monitor your health through blood tests, physical exams, and by asking you about any side effects.  The main goals are to assess the safety and tolerability of the cream, including any side effects, and to measure how much of the drug gets into your bloodstream.  Secondary goals include evaluating the cream's effect on your HS lesions, pain, itching, and quality of life.  You will have regular visits during the 4-week treatment period and potentially for a longer extension period, followed by a final safety follow-up visit.",
                  "investigator_name": "Dr. Ira Thorla",
                  "site_location": "Baton Rouge, LA",
                  "protocol_summary": "This is a Phase 1, open-label (not blinded), single-group study sponsored by Incyte Corporation.  The study will be conducted at multiple locations (multicenter) and is designed to evaluate the safety and tolerability of ruxolitinib cream. The total study duration, including screening, treatment, and follow-up, could be up to approximately 24 weeks.\n\nThis study is for adults and adolescents aged 12 to 75 years who have been diagnosed with hidradenitis suppurativa (HS) for at least 6 months.  To be eligible, you must have at least 4 abscesses and inflammatory nodules affecting at least 3 different areas of your body, with a total treatment area greater than 20% of your body surface area.  You may not be eligible if you have certain other skin conditions or are taking specific medications. During the study, you will be asked to apply the study cream twice daily to all affected areas and attend regular visits for check-ups and assessments.\n\nIn this study, you will apply ruxolitinib 1.5% cream twice daily to all affected areas for 4 weeks.  Researchers will monitor your health through blood tests, physical exams, and by asking you about any side effects.  The main goals are to assess the safety and tolerability of the cream, including any side effects, and to measure how much of the drug gets into your bloodstream.  Secondary goals include evaluating the cream's effect on your HS lesions, pain, itching, and quality of life.  You will have regular visits during the 4-week treatment period and potentially for a longer extension period, followed by a final safety follow-up visit.",
                  "total_sites": 1,
                  "similarity_score": 0.8163552408254671
                },
                {
                  "id": 51,
                  "trial_name": "A Phase 2, Multi-Center Study Consisting of a Randomized, Placebo-Controlled Period, Followed by an Open-Label Extension Period to Assess the Efficacy, Safety, and Tolerability of Tibulizumab in Adults with Hidradenitis Suppurativa",
                  "conditions": "Hidradenitis Suppurativa",
                  "description": "This is a Phase 2 research study, meaning it's one of the early stages of testing a new drug called tibulizumab.  The study is randomized, which means participants are assigned to different treatment groups by chance, like flipping a coin.  It's also placebo-controlled and double-blind, meaning some participants will receive a placebo (an inactive substance) and neither the participants nor the researchers will know who is getting which treatment until the end of the study.  This helps ensure the results are accurate. The study is sponsored by Zura Bio Inc. and will be conducted at approximately 53 sites across the United States, Canada, and Europe.  The maximum time a participant will be in the study is about 44 weeks.\n\nThis study is looking for adults with moderate to severe hidradenitis suppurativa (HS). To be eligible, you must have HS lesions in at least two different areas of your body, with at least one area being Hurley Stage II or III, and a total abscess and inflammatory nodule count of 5 or more.  You won't be able to participate if you have more than 20 draining fistulas.  Up to 30% of participants may have previously used anti-TNF\u03b1 therapies, and up to 40% may have Hurley Stage III HS.  During the study, you'll receive injections and attend regular check-ups at the study site.  Your participation will involve several visits over approximately 44 weeks, including a screening period, a treatment period, and a follow-up period.\n\nIn this study, you'll receive either tibulizumab (150mg or 300mg) or a placebo by subcutaneous injection (under the skin) every 4 weeks, with an extra dose at week 2.  Researchers will be tracking the number of your HS lesions, how your HS affects your quality of life (using questionnaires like the DLQI and HS-PtGA), and any pain you experience.  The main goal is to see how much tibulizumab reduces the number of abscesses and inflammatory nodules.  They'll also be checking your overall health through blood tests and other assessments.  You'll need to visit the study center approximately 13 times throughout the study, including a screening visit, treatment visits, and a final follow-up visit.",
                  "investigator_name": "Dr. Ira Thorla",
                  "site_location": "Baton Rouge, LA",
                  "protocol_summary": "This is a Phase 2 research study, meaning it's one of the early stages of testing a new drug called tibulizumab.  The study is randomized, which means participants are assigned to different treatment groups by chance, like flipping a coin.  It's also placebo-controlled and double-blind, meaning some participants will receive a placebo (an inactive substance) and neither the participants nor the researchers will know who is getting which treatment until the end of the study.  This helps ensure the results are accurate. The study is sponsored by Zura Bio Inc. and will be conducted at approximately 53 sites across the United States, Canada, and Europe.  The maximum time a participant will be in the study is about 44 weeks.\n\nThis study is looking for adults with moderate to severe hidradenitis suppurativa (HS). To be eligible, you must have HS lesions in at least two different areas of your body, with at least one area being Hurley Stage II or III, and a total abscess and inflammatory nodule count of 5 or more.  You won't be able to participate if you have more than 20 draining fistulas.  Up to 30% of participants may have previously used anti-TNF\u03b1 therapies, and up to 40% may have Hurley Stage III HS.  During the study, you'll receive injections and attend regular check-ups at the study site.  Your participation will involve several visits over approximately 44 weeks, including a screening period, a treatment period, and a follow-up period.\n\nIn this study, you'll receive either tibulizumab (150mg or 300mg) or a placebo by subcutaneous injection (under the skin) every 4 weeks, with an extra dose at week 2.  Researchers will be tracking the number of your HS lesions, how your HS affects your quality of life (using questionnaires like the DLQI and HS-PtGA), and any pain you experience.  The main goal is to see how much tibulizumab reduces the number of abscesses and inflammatory nodules.  They'll also be checking your overall health through blood tests and other assessments.  You'll need to visit the study center approximately 13 times throughout the study, including a screening visit, treatment visits, and a final follow-up visit.",
                  "total_sites": 3,
                  "similarity_score": 0.789239772908223
                },
                {
                  "id": 14,
                  "trial_name": "Clinical Trial 250-13951-306",
                  "conditions": "Female Pattern Hair Loss (Androgenetic Alopecia)",
                  "description": null,
                  "investigator_name": "Dr. Ira Thorla",
                  "site_location": "Baton Rouge, LA",
                  "protocol_summary": "This clinical trial aims to investigate the effectiveness and safety of an oral medication called VDPHL01 for treating female pattern hair loss (androgenetic alopecia).  The study will evaluate two different dosing regimens of VDPHL01: twice daily and once daily.  It will compare these regimens against a placebo to see if the medication promotes hair growth and improves patient satisfaction with their hair.\n\nWomen aged 18-65 with mild to moderate hair loss, as measured by the Savin Scale, are eligible to participate.  Key inclusion criteria include good general health, adequate kidney and liver function, and a commitment to maintaining consistent hair care routines throughout the study.  Women who are pregnant, breastfeeding, have certain medical conditions (like uncontrolled blood pressure or a history of heart problems), or have recently used other hair growth treatments are excluded.\n\nThe study will last approximately 13 months and consist of two parts. Part A is a 6-month placebo-controlled period, where participants are randomly assigned to one of four groups: VDPHL01 twice daily, VDPHL01 once daily plus placebo, placebo twice daily, or placebo twice daily.  Part B is a 6-month treatment extension, where those initially receiving placebo will start taking VDPHL01 according to their initial group assignment, while those already on VDPHL01 will continue.  Participants will have regular clinic visits (approximately 11) for assessments including physical exams, blood and urine tests, electrocardiograms, photographs of the scalp, and questionnaires about their hair and quality of life. A small group of participants will also take part in interviews.  A final follow-up will occur one month after the treatment period ends.\n",
                  "total_sites": 2,
                  "similarity_score": 0.7864790864830788
                }
              ],
              "semantic_search": true
            },
            "response_time": 43.826225996017456,
            "timestamp": "2025-12-16T07:36:48.188634"
          },
          {
            "user_message": "Baton Rouge, LA",
            "bot_response": "Thanks for confirming. I've found the trials currently available for Hidradenitis Suppurativa near Baton Rouge. Would you like to go through a few questions to see if you might be eligible for any of them?",
            "metadata": {
              "session_id": "AUTO_TEST_random_001",
              "current_state": "trials_shown",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "clarify_request",
              "entities_collected": {
                "condition": null,
                "location": "Baton Rouge, LA",
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "clarify_request",
                "parameters": {},
                "response_text": "Thanks for confirming. I've found the trials currently available for Hidradenitis Suppurativa near Baton Rouge. Would you like to go through a few questions to see if you might be eligible for any of them?",
                "new_state": "trials_shown",
                "collect_entities": [],
                "metadata": {
                  "reasoning": "The user is in the 'trials_shown' state and has repeated the location that was just used for the search. This indicates they may be unsure of the next step. The best action is to clarify their intent and gently guide them toward the most logical next action, which is checking eligibility for the trials we've found. This response confirms their location, reminds them of the current context, and proposes a clear path forward without being pushy."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "general_response": true
            },
            "response_time": 22.544103145599365,
            "timestamp": "2025-12-16T07:37:10.733172"
          },
          {
            "user_message": "Yes, that's correct",
            "bot_response": "I notice we started checking your eligibility for the hidradenitis suppurativa trial earlier (answered 5 of 6 questions). Would you like to:\n\n1. Continue where we left off\n2. Start over with fresh information\n3. Look for different trials instead",
            "metadata": {
              "session_id": "AUTO_TEST_random_001",
              "current_state": "prescreening_resume_choice",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "start_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "start_prescreening",
                "parameters": {},
                "response_text": "Great! I can help with that. I'll ask a few questions to see if you might be a match for any of these trials. This is just a preliminary check, and the final decision is always up to the study team.\n\nFirst, could you please tell me your age?",
                "new_state": "prescreening_in_progress",
                "collect_entities": [
                  "age"
                ],
                "metadata": {
                  "reasoning": "The user has explicitly confirmed their desire to begin the eligibility prescreening process after being shown a list of trials. The current state is 'trials_shown' and the user's intent is a clear 'yes'. Therefore, the most logical and helpful action is to initiate the prescreening process. The response acknowledges their confirmation, sets clear expectations for the prescreening, and asks the first common eligibility question (age) to move the conversation forward. The state is updated to 'prescreening_in_progress' to reflect this new phase."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "existing_session_id": 191,
              "answered_questions": 5,
              "total_questions": 6,
              "trial_id": 80
            },
            "response_time": 17.302510023117065,
            "timestamp": "2025-12-16T07:37:28.036164"
          },
          {
            "user_message": "Yes, please continue",
            "bot_response": "I had trouble evaluating your eligibility. Let me help you search for other trials or contact the study coordinator directly.",
            "metadata": {
              "session_id": "AUTO_TEST_random_001",
              "current_state": "initial",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Great, let's pick up where we left off. The next question is: Have you previously been treated with a biologic medication (such as Humira or Cosentyx) for your Hidradenitis Suppurativa?",
                "new_state": "prescreening_in_progress",
                "collect_entities": [
                  "boolean_answer",
                  "medication"
                ],
                "metadata": {
                  "reasoning": "The user is in the 'prescreening_resume_choice' state and has explicitly confirmed they want to continue with the prescreening ('Yes, please continue'). The most appropriate action is to resume the eligibility check by asking the next question in the sequence and transitioning the state to 'prescreening_in_progress'."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "prescreening_error": "'coroutine' object has no attribute 'summary_text'"
            },
            "response_time": 22.019885063171387,
            "timestamp": "2025-12-16T07:37:50.056468"
          },
          {
            "user_message": "Yes, please continue",
            "bot_response": "I had trouble evaluating your eligibility. Let me help you search for other trials or contact the study coordinator directly.",
            "metadata": {
              "session_id": "AUTO_TEST_random_001",
              "current_state": "initial",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": "yes",
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Great, let's continue. The next question is: Are you 18 years of age or older?",
                "new_state": "prescreening",
                "collect_entities": [
                  "age",
                  "boolean_answer"
                ],
                "metadata": {
                  "reasoning": "The user has explicitly confirmed their desire to proceed with the eligibility check by saying 'Yes, please continue'. The most logical next step is to ask the next question in the prescreening flow. The chosen action, `continue_prescreening`, reflects this. The response is designed to be a common and straightforward eligibility question (age), which moves the conversation forward effectively. The state is updated to `prescreening` to accurately track the conversation's progress."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "prescreening_error": "'coroutine' object has no attribute 'summary_text'"
            },
            "response_time": 28.63275694847107,
            "timestamp": "2025-12-16T07:38:18.689593"
          }
        ],
        "final_state": "completed",
        "total_turns": 14,
        "total_questions_asked": 6,
        "errors": [
          {
            "type": "unexpected_state",
            "bot_response": "I notice we started checking your eligibility for the hidradenitis suppurativa trial earlier (answer"
          },
          {
            "type": "unexpected_state",
            "bot_response": "I had trouble evaluating your eligibility. Let me help you search for other trials or contact the st"
          }
        ]
      },
      "validation": {
        "passed": false,
        "overall_score": 64.0,
        "crash_prevention": {
          "passed": true,
          "score": 100.0,
          "error_count": 0,
          "errors": [],
          "failures": []
        },
        "eligibility_accuracy": {
          "passed": false,
          "score": 0.0,
          "reason": "Could not extract eligibility result",
          "failures": [
            {
              "type": "eligibility_logic_error",
              "reason": "No eligibility determination found in conversation",
              "likely_location": "core/prescreening/gemini_prescreening_manager.py:evaluate_eligibility()",
              "severity": "high"
            }
          ]
        },
        "conversation_quality": {
          "passed": true,
          "score": 70.0,
          "total_questions_asked": 6,
          "issues": [
            "Repeated question: I'm here to help you find clinical trials. What co...",
            "Repeated question: Great! I found 5 clinical trial(s) available in Ba..."
          ],
          "failures": [
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I'm here to help you find clinical trials. What co...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: Great! I found 5 clinical trial(s) available in Ba...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            }
          ]
        },
        "edge_case_handling": {
          "passed": true,
          "score": 100.0,
          "applicable": false,
          "failures": []
        },
        "performance": {
          "passed": false,
          "score": 40.0,
          "avg_response_time": 31.48797414984022,
          "max_response_time": 57.816179037094116,
          "status": "slow",
          "failures": [
            {
              "type": "performance_issue",
              "avg_response_time": 31.48797414984022,
              "max_response_time": 57.816179037094116,
              "severity": "low",
              "recommendation": "Investigate slow API responses or Gemini API delays"
            }
          ]
        },
        "failure_points": [
          {
            "type": "eligibility_logic_error",
            "reason": "No eligibility determination found in conversation",
            "likely_location": "core/prescreening/gemini_prescreening_manager.py:evaluate_eligibility()",
            "severity": "high"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I'm here to help you find clinical trials. What co...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: Great! I found 5 clinical trial(s) available in Ba...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "performance_issue",
            "avg_response_time": 31.48797414984022,
            "max_response_time": 57.816179037094116,
            "severity": "low",
            "recommendation": "Investigate slow API responses or Gemini API delays"
          }
        ],
        "recommendations": [
          "\u26a0\ufe0f HIGH: Review eligibility evaluation logic in gemini_prescreening_manager.py",
          "\u2139\ufe0f LOW: Slow response times. Optimize API calls or consider caching."
        ]
      },
      "timestamp": "2025-12-16T07:38:18.690581"
    },
    {
      "patient_id": "AUTO_TEST_targeted_gout_000",
      "patient_profile": {
        "patient_id": "AUTO_TEST_targeted_gout_000",
        "profile_type": "targeted",
        "demographics": {
          "age": 45,
          "gender": "female",
          "location": "New Orleans, LA",
          "name": "Test Gout Patient",
          "first_name": "Test",
          "last_name": "Patient"
        },
        "medical_history": {
          "primary_condition": "Gout",
          "conditions": [
            "Gout",
            "Hypertension"
          ],
          "medications": [
            "Lisinopril"
          ],
          "duration_years": 3,
          "flares_per_year": 4,
          "uric_acid_level": 8.5
        },
        "expected_behavior": {
          "should_find_trials": true,
          "likely_eligible": true,
          "expected_question_count_range": [
            5,
            8
          ],
          "target_trial_keywords": [
            "gout"
          ]
        }
      },
      "conversation_result": {
        "session_id": "AUTO_TEST_targeted_gout_000",
        "patient_id": "AUTO_TEST_targeted_gout_000",
        "conversation_log": [
          {
            "user_message": "Gout trials in New Orleans, LA",
            "bot_response": "Great! I found 5 clinical trial(s) available in New Orleans, LA:\n\n**Dr. Patrick Dennis**\n  \u2022 Gout (4 trials)\n  \u2022 Overweight (1 trial)\n\nWould you like to:\n1. Check your eligibility for any of these trials?\n2. Learn more about a specific condition?\n3. See trials in a different location?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_gout_000",
              "current_state": "trials_shown",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "search_trials",
              "entities_collected": {
                "condition": "Gout",
                "location": "New Orleans",
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "search_trials",
                "parameters": {
                  "condition": "Gout",
                  "location": "New Orleans, LA"
                },
                "response_text": "Of course. I can look for gout clinical trials for you in New Orleans, LA. One moment while I search...",
                "new_state": "awaiting_user_choice",
                "collect_entities": [],
                "metadata": {
                  "reasoning": "The user has provided both a specific medical condition ('Gout') and a location ('New Orleans, LA'). Since both required pieces of information for a search are present, the correct action is to proceed with the 'search_trials' action. The response confirms the user's request and sets the expectation that a search is being performed."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "trials_found": 5,
              "condition": "Gout",
              "location": "New Orleans, LA",
              "trials_data": [
                {
                  "id": 2,
                  "trial_name": "A Phase 3 Randomized, Double-blind, Multi-center, Placebo-controlled Study to Evaluate the Efficacy and Safety of AR882 in Participants with Gout",
                  "conditions": "Gout",
                  "description": "",
                  "investigator_name": "Dr. Patrick Dennis",
                  "site_location": "New Orleans, LA",
                  "protocol_summary": "The clinical trial, identified as Protocol AR882-301, is a Phase 3, randomized, double-blind, multi-center, placebo-controlled study designed to evaluate the efficacy and safety of the investigational drug AR882 in participants with gout. Sponsored by Arthrosi Therapeutics, Inc., this trial will be conducted across approximately 100 sites in the United States and Canada. The primary objective is to assess the ability of AR882 to reduce serum uric acid (sUA) levels in participants, with a specific focus on achieving sUA levels below 6.0 mg/dL by Month 6.\n\nParticipants in the trial will be randomly assigned to receive either AR882 or a placebo. The study will be double-blind, meaning neither the participants nor the investigators will know which treatment each participant is receiving. The intervention involves the administration of AR882, with the primary aim of evaluating its efficacy in lowering sUA levels and reducing tophus burden. The CAPER method will be employed to assess the response of target tophi, with evaluations conducted at Months 6 and 12 to determine the presence of disease progression.\n\nThe primary endpoint of the study is the proportion of participants achieving sUA levels below 6.0 mg/dL at Month 6. Secondary endpoints include the reduction of tophus burden and the maintenance of sUA levels below 6.0 mg/dL at Months 9 and 12, alongside the absence of gout flares over a three-month period. The trial will last until all participants have completed 12 months or have discontinued. Notable inclusion criteria include a diagnosis of gout and baseline tophi, while exclusion criteria may involve other significant health conditions that could interfere with the study's outcomes.",
                  "total_sites": 17,
                  "similarity_score": 0.8027487136996964
                },
                {
                  "id": 66,
                  "trial_name": "A Randomized, Double-blind, Multicenter, Colchicine and Placebo-controlled Study to Evaluate the Efficacy and Safety of ABP-745 in Subjects with an Acute Gout Flare",
                  "conditions": "Gout",
                  "description": "This is a Phase II, randomized, double-blind, placebo-controlled, multi-center study sponsored by Atom Therapeutics Co., Ltd.  The study will be conducted in the United States, Australia, and China and will last approximately 6 months for each participant, with the possibility of re-screening and continuing for another 6 months if no flare occurs in the initial period.  This means that neither you nor your doctor will know which treatment you are receiving, and participants will be randomly assigned to different treatment groups.  The study aims to determine how well ABP-745 works to treat acute gout flares compared to colchicine and a placebo.\n\nThis study is looking for men and women aged 18-70 with a BMI between 18 and 40 who have been diagnosed with gout and have experienced at least two gout flares in the past year.  You must be able to contact the study site and receive your first dose within 10 hours of a new flare starting, and you must be able to return to the site 24 hours after the first dose.  You will need to be able to attend several visits at the study site over a 7-day period during a flare and a final visit after treatment, as well as a safety follow-up phone call.  You may not be eligible to participate if you have certain other medical conditions or are taking certain medications.  Your doctor will discuss these criteria with you in more detail.\n\nParticipants will be randomly assigned to receive either ABP-745 (at one of two doses), colchicine, or a placebo.  The study will measure pain levels, tenderness, and swelling in your most affected joint.  The main goals are to see how much ABP-745 reduces pain at 24 hours after the first dose compared to colchicine and placebo.  Other measurements will include pain levels at later time points, the percentage of people who experience significant pain reduction, and how the treatment affects markers of inflammation in your blood.  You will take the study medication twice daily for 7 days during a flare.  You will have several visits to the study site during this time for assessments and blood draws.",
                  "investigator_name": "Dr. Patrick Dennis",
                  "site_location": "New Orleans, LA",
                  "protocol_summary": "This is a Phase II, randomized, double-blind, placebo-controlled, multi-center study sponsored by Atom Therapeutics Co., Ltd.  The study will be conducted in the United States, Australia, and China and will last approximately 6 months for each participant, with the possibility of re-screening and continuing for another 6 months if no flare occurs in the initial period.  This means that neither you nor your doctor will know which treatment you are receiving, and participants will be randomly assigned to different treatment groups.  The study aims to determine how well ABP-745 works to treat acute gout flares compared to colchicine and a placebo.\n\nThis study is looking for men and women aged 18-70 with a BMI between 18 and 40 who have been diagnosed with gout and have experienced at least two gout flares in the past year.  You must be able to contact the study site and receive your first dose within 10 hours of a new flare starting, and you must be able to return to the site 24 hours after the first dose.  You will need to be able to attend several visits at the study site over a 7-day period during a flare and a final visit after treatment, as well as a safety follow-up phone call.  You may not be eligible to participate if you have certain other medical conditions or are taking certain medications.  Your doctor will discuss these criteria with you in more detail.\n\nParticipants will be randomly assigned to receive either ABP-745 (at one of two doses), colchicine, or a placebo.  The study will measure pain levels, tenderness, and swelling in your most affected joint.  The main goals are to see how much ABP-745 reduces pain at 24 hours after the first dose compared to colchicine and placebo.  Other measurements will include pain levels at later time points, the percentage of people who experience significant pain reduction, and how the treatment affects markers of inflammation in your blood.  You will take the study medication twice daily for 7 days during a flare.  You will have several visits to the study site during this time for assessments and blood draws.",
                  "total_sites": 4,
                  "similarity_score": 0.7992400049183908
                },
                {
                  "id": 74,
                  "trial_name": "A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Dotinurad Compared With Allopurinol in Adult Participants With Hyperuricemia Associated With Gout",
                  "conditions": "Gout",
                  "description": "This is a Phase 3, randomized, double-blind, multicenter study sponsored by Crystalys Therapeutics, Inc.  The study will be conducted at up to 100 sites across North America and Europe and is expected to last approximately 2.5 years.  \"Double-blind\" means neither you nor your study doctor will know which medicine you are taking. \"Randomized\" means you will be assigned to a treatment group by chance, like flipping a coin.  This helps ensure the results are unbiased.\n\nThis study is for adults with gout who have experienced at least two gout flares in the past year and have been taking a stable dose of allopurinol (300-600mg daily, or 200mg for those with moderate kidney problems) for at least 3 months.  You must also have a serum uric acid (sUA) level of 6.5 mg/dL or higher at two screening visits.  You will not be able to participate if you have certain other medical conditions (these will be discussed during screening).  During the study, you will be asked to keep a diary of your medication intake, any gout flares you experience, and any related healthcare visits.  \n\nIn this study, you will receive either dotinurad (the investigational drug) or allopurinol.  Dotinurad will be given in increasing doses over the first 12 weeks.  Allopurinol will be given at the same dose you were taking before the study began.  The study will measure how well each medication lowers sUA levels in your blood, reduces the number of gout flares you experience, and assess any side effects.  The main goal is to see if dotinurad is as effective as allopurinol in lowering sUA at 24 weeks.  Other goals include evaluating the impact on gout flares and overall safety.  You will have regular check-ups every 2 weeks initially, then every 4 weeks, and will be asked to complete questionnaires about your health.  Even if you stop taking the study medication, you will be encouraged to continue with the follow-up visits.",
                  "investigator_name": "Dr. Patrick Dennis",
                  "site_location": "New Orleans, LA",
                  "protocol_summary": "This is a Phase 3, randomized, double-blind, multicenter study sponsored by Crystalys Therapeutics, Inc.  The study will be conducted at up to 100 sites across North America and Europe and is expected to last approximately 2.5 years.  \"Double-blind\" means neither you nor your study doctor will know which medicine you are taking. \"Randomized\" means you will be assigned to a treatment group by chance, like flipping a coin.  This helps ensure the results are unbiased.\n\nThis study is for adults with gout who have experienced at least two gout flares in the past year and have been taking a stable dose of allopurinol (300-600mg daily, or 200mg for those with moderate kidney problems) for at least 3 months.  You must also have a serum uric acid (sUA) level of 6.5 mg/dL or higher at two screening visits.  You will not be able to participate if you have certain other medical conditions (these will be discussed during screening).  During the study, you will be asked to keep a diary of your medication intake, any gout flares you experience, and any related healthcare visits.  \n\nIn this study, you will receive either dotinurad (the investigational drug) or allopurinol.  Dotinurad will be given in increasing doses over the first 12 weeks.  Allopurinol will be given at the same dose you were taking before the study began.  The study will measure how well each medication lowers sUA levels in your blood, reduces the number of gout flares you experience, and assess any side effects.  The main goal is to see if dotinurad is as effective as allopurinol in lowering sUA at 24 weeks.  Other goals include evaluating the impact on gout flares and overall safety.  You will have regular check-ups every 2 weeks initially, then every 4 weeks, and will be asked to complete questionnaires about your health.  Even if you stop taking the study medication, you will be encouraged to continue with the follow-up visits.",
                  "total_sites": 13,
                  "similarity_score": 0.7947402273735418
                }
              ],
              "semantic_search": true
            },
            "response_time": 21.362944841384888,
            "timestamp": "2025-12-16T07:45:27.463655"
          },
          {
            "user_message": "Yes, check my eligibility",
            "bot_response": "Great! I'll help you check your eligibility.\n\nI need to ask you a few questions about the gout trial.\n\n**Question 1 of 5:** What is your age?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_gout_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "start_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "start_prescreening",
                "parameters": {},
                "response_text": "Of course. I can help with that. I'll ask a few simple questions to see if you might be a match for one of the Gout trials in New Orleans. Please keep in mind this is just a preliminary check and not a guarantee of eligibility.\n\nDo you have a specific trial you're interested in, or should we start with the first one?",
                "new_state": "prescreening_started",
                "collect_entities": [
                  "trial_name",
                  "number"
                ],
                "metadata": {
                  "reasoning": "The user has explicitly confirmed they want to check their eligibility after being shown a list of trials. The state is 'trials_shown', and we have the necessary condition and location. The next logical step is to begin the prescreening process. The response confirms the user's request, sets expectations about the preliminary nature of the screening, and asks which trial they'd like to start with, as multiple trials were likely presented."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "prescreening_started": true,
              "trial_id": 2,
              "trial_name": "A Phase 3 Randomized, Double-blind, Multi-center, Placebo-controlled Study to Evaluate the Efficacy and Safety of AR882 in Participants with Gout",
              "current_question_index": 0,
              "total_questions": 5,
              "current_question": "What is your age?",
              "expected_answer_type": "number"
            },
            "response_time": 24.928256034851074,
            "timestamp": "2025-12-16T07:45:52.395790"
          },
          {
            "user_message": "45",
            "bot_response": "Got it.\n\nWhat is your current weight and height?",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_gout_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": 45,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thanks for sharing that. Just a couple more questions to check if this Gout study might be a good fit. Have you been diagnosed with Gout by a healthcare professional?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "boolean_answer"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session and has just provided their age in response to the previous question. The most logical and helpful action is to continue the prescreening process by asking the next relevant eligibility question. This moves the user forward in determining their potential eligibility for the trial."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "current_question_index": 1,
              "total_questions": 5,
              "current_question": "What is your current weight and height?",
              "expected_answer_type": "text",
              "parsed_answer": {
                "interpretation": "number",
                "confidence": 1.0
              }
            },
            "response_time": 23.11941623687744,
            "timestamp": "2025-12-16T07:46:15.515743"
          },
          {
            "user_message": "6'3\"",
            "bot_response": "I found your height (6'3\") but couldn't determine your weight. Could you specify your weight?\n\nExamples: '180 pounds', '180 lbs', '215', or '82 kg'",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_gout_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": "6'3\"",
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Great, thanks for sharing your height. Could you also tell me your current weight?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "number"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and has provided their height in response to a previous question. The most logical next step is to continue the prescreening process by asking for their weight, as height and weight are often used together to calculate BMI, a common eligibility criterion. The state remains 'prescreening_active' as we are still gathering information for the eligibility check."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 18.301130056381226,
            "timestamp": "2025-12-16T07:46:33.817615"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_gout_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Great, thanks for confirming. To continue, could you please tell me your approximate weight in pounds? This helps us check against the trial's specific criteria.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session and responded 'Yes' to a clarification question about their weight, without providing the actual value. The best action is to continue the prescreening by gently re-prompting for the specific information needed (their weight) to move forward with the eligibility check. The state remains `prescreening_active` as we are still in the process of collecting information."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 23.648818969726562,
            "timestamp": "2025-12-16T07:46:57.467064"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_gout_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Great. To continue with the prescreening, could you please provide your height and weight? This information is often required for clinical trials.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and has affirmed their readiness to continue by saying 'Yes'. The previous turn likely asked for information that wasn't provided in their response. The best action is to continue the prescreening process by explicitly asking for the required information (height and weight, as inferred from the context) to move them forward in the eligibility check."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 27.470927000045776,
            "timestamp": "2025-12-16T07:47:24.938655"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_targeted_gout_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thanks for confirming. To move forward with the eligibility check, could you please tell me your height and weight? This is a common requirement for many studies.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session and provided a non-specific 'Yes' response, likely to a previous question that required specific data (like height and weight, as hinted by the OpenAI reasoning). The user's intent is to continue, but they did not provide the necessary information. The best action is to gently re-prompt for the required information to keep the prescreening process moving forward. The state remains 'prescreening_active' as we are still in the middle of the questionnaire."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 1
            },
            "response_time": 36.66876006126404,
            "timestamp": "2025-12-16T07:48:01.608203"
          }
        ],
        "final_state": "failed",
        "total_turns": 7,
        "total_questions_asked": 5,
        "errors": [
          {
            "type": "timeout",
            "message": "Yes",
            "response_time": 60.71875786781311
          },
          {
            "type": "conversation_failure",
            "error": "",
            "state": "prescreening_active",
            "timestamp": "2025-12-16T07:49:02.327668"
          }
        ]
      },
      "validation": {
        "passed": false,
        "overall_score": 24.0,
        "crash_prevention": {
          "passed": false,
          "score": 0.0,
          "error_count": 2,
          "errors": [
            {
              "type": "timeout",
              "message": "Yes",
              "response_time": 60.71875786781311
            },
            {
              "type": "conversation_failure",
              "error": "",
              "state": "prescreening_active",
              "timestamp": "2025-12-16T07:49:02.327668"
            }
          ],
          "failures": [
            {
              "type": "crash",
              "error_type": "timeout",
              "error_message": "Unknown error",
              "likely_location": "aiohttp timeout in conversation_simulator.py or slow Gemini API response",
              "severity": "critical"
            },
            {
              "type": "crash",
              "error_type": "conversation_failure",
              "error_message": "",
              "likely_location": "Unknown - check full error trace",
              "severity": "critical"
            }
          ]
        },
        "eligibility_accuracy": {
          "passed": false,
          "score": 0.0,
          "reason": "Prescreening did not complete",
          "failures": [
            {
              "type": "eligibility_logic_error",
              "reason": "Prescreening flow did not complete",
              "final_state": "failed",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py",
              "severity": "high"
            }
          ]
        },
        "conversation_quality": {
          "passed": true,
          "score": 70.0,
          "total_questions_asked": 5,
          "issues": [
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y..."
          ],
          "failures": [
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            }
          ]
        },
        "edge_case_handling": {
          "passed": true,
          "score": 100.0,
          "applicable": false,
          "failures": []
        },
        "performance": {
          "passed": false,
          "score": 40.0,
          "avg_response_time": 25.071464742933,
          "max_response_time": 36.66876006126404,
          "status": "slow",
          "failures": [
            {
              "type": "performance_issue",
              "avg_response_time": 25.071464742933,
              "max_response_time": 36.66876006126404,
              "severity": "low",
              "recommendation": "Investigate slow API responses or Gemini API delays"
            }
          ]
        },
        "failure_points": [
          {
            "type": "crash",
            "error_type": "timeout",
            "error_message": "Unknown error",
            "likely_location": "aiohttp timeout in conversation_simulator.py or slow Gemini API response",
            "severity": "critical"
          },
          {
            "type": "crash",
            "error_type": "conversation_failure",
            "error_message": "",
            "likely_location": "Unknown - check full error trace",
            "severity": "critical"
          },
          {
            "type": "eligibility_logic_error",
            "reason": "Prescreening flow did not complete",
            "final_state": "failed",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py",
            "severity": "high"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "performance_issue",
            "avg_response_time": 25.071464742933,
            "max_response_time": 36.66876006126404,
            "severity": "low",
            "recommendation": "Investigate slow API responses or Gemini API delays"
          }
        ],
        "recommendations": [
          "\ud83d\udea8 CRITICAL: Fix crashes and exceptions. Review error logs and add error handling.",
          "\u26a0\ufe0f HIGH: Review eligibility evaluation logic in gemini_prescreening_manager.py",
          "\u2139\ufe0f LOW: Slow response times. Optimize API calls or consider caching."
        ]
      },
      "timestamp": "2025-12-16T07:49:02.327829"
    },
    {
      "patient_id": "AUTO_TEST_edge_age_000",
      "patient_profile": {
        "patient_id": "AUTO_TEST_edge_age_000",
        "profile_type": "edge_case",
        "demographics": {
          "age": 75,
          "gender": "non-binary",
          "location": "New Orleans, LA",
          "name": "Edge Age Patient",
          "first_name": "Edge",
          "last_name": "Patient"
        },
        "medical_history": {
          "primary_condition": "Hypertension",
          "conditions": [
            "Hypertension"
          ],
          "medications": [
            "Lisinopril"
          ],
          "duration_years": 1
        },
        "expected_behavior": {
          "should_find_trials": true,
          "likely_eligible": true,
          "expected_question_count_range": [
            3,
            8
          ],
          "edge_case_type": "extreme_age"
        }
      },
      "conversation_result": {
        "session_id": "AUTO_TEST_edge_age_000",
        "patient_id": "AUTO_TEST_edge_age_000",
        "conversation_log": [
          {
            "user_message": "Hypertension trials in New Orleans, LA",
            "bot_response": "Great! I found 5 clinical trial(s) available in New Orleans, LA:\n\n**Dr. Patrick Dennis**\n  \u2022 Uncontrolled Hypertension (1 trial)\n  \u2022 Gout (3 trials)\n  \u2022 Overweight (1 trial)\n\nWould you like to:\n1. Check your eligibility for any of these trials?\n2. Learn more about a specific condition?\n3. See trials in a different location?",
            "metadata": {
              "session_id": "AUTO_TEST_edge_age_000",
              "current_state": "trials_shown",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "search_trials",
              "entities_collected": {
                "condition": "Hypertension",
                "location": "New Orleans",
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "search_trials",
                "parameters": {
                  "condition": "Hypertension",
                  "location": "New Orleans, LA"
                },
                "response_text": "Of course. I can help you look for hypertension trials in New Orleans, LA. Let me see what I can find for you. Once I have the results, I can also help you check if you might be a good fit for any of them.",
                "new_state": "awaiting_search_results",
                "collect_entities": [],
                "metadata": {
                  "reasoning": "The user has provided both a specific medical condition ('Hypertension') and a location ('New Orleans, LA'). The intent is clearly to find clinical trials. Therefore, the correct action is to execute the search with the provided parameters. The response confirms the user's request, states the action being taken, and proactively offers the next logical step (eligibility prescreening) to be helpful."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "trials_found": 5,
              "condition": "Hypertension",
              "location": "New Orleans, LA",
              "trials_data": [
                {
                  "id": 106,
                  "trial_name": "A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Study of Modified Release RTN-001 In Patients with Uncontrolled Hypertension",
                  "conditions": "Uncontrolled Hypertension",
                  "description": "This is a Phase 2b clinical research study sponsored by Retension Pharmaceuticals, Inc., which will take place at multiple medical centers across the United States. The study is designed as a randomized, double-blind, placebo-controlled trial, which means you will be assigned by chance (like a coin toss) to receive either the investigational drug or a placebo (an inactive substance). Neither you nor your study doctor will know which treatment you are receiving, which helps ensure the results are unbiased. Your total participation will last approximately 16 weeks, which includes an initial screening and run-in period, a 12-week treatment period, and a final follow-up phone call two weeks after your last dose.\n\nThis study is seeking approximately 280 adults between the ages of 18 and 70 who have uncontrolled high blood pressure. To be eligible, you must currently be taking a stable regimen of two or more blood pressure medications, but still have a blood pressure reading of at least 130/80 mm Hg. There are several reasons you may not be able to participate, such as having very high blood pressure (over 170/110 mm Hg), a recent history of a heart attack or stroke, or current use of certain medications like nitrates or alpha-blockers. The study aims to enroll a diverse population, including patients with resistant hypertension who are on three or more medications.\n\nIf you qualify and choose to participate, you will first complete a 2-week period taking a placebo to ensure you can follow the study requirements. Afterwards, you will be randomly assigned to take a once-daily pill for 12 weeks, which will be one of three different doses of the investigational drug RTN-001 or a matching placebo. The main purpose of the study is to see if RTN-001 can effectively lower systolic blood pressure. Throughout the study, you will attend several clinic visits (at weeks 2, 4, 8, and 12) for procedures that include blood pressure measurements in the office, wearing a 24-hour blood pressure monitor at home, blood tests, heart tracings (ECGs), and physical exams.",
                  "investigator_name": "Dr. Patrick Dennis",
                  "site_location": "New Orleans, LA",
                  "protocol_summary": "This is a Phase 2b clinical research study sponsored by Retension Pharmaceuticals, Inc., which will take place at multiple medical centers across the United States. The study is designed as a randomized, double-blind, placebo-controlled trial, which means you will be assigned by chance (like a coin toss) to receive either the investigational drug or a placebo (an inactive substance). Neither you nor your study doctor will know which treatment you are receiving, which helps ensure the results are unbiased. Your total participation will last approximately 16 weeks, which includes an initial screening and run-in period, a 12-week treatment period, and a final follow-up phone call two weeks after your last dose.\n\nThis study is seeking approximately 280 adults between the ages of 18 and 70 who have uncontrolled high blood pressure. To be eligible, you must currently be taking a stable regimen of two or more blood pressure medications, but still have a blood pressure reading of at least 130/80 mm Hg. There are several reasons you may not be able to participate, such as having very high blood pressure (over 170/110 mm Hg), a recent history of a heart attack or stroke, or current use of certain medications like nitrates or alpha-blockers. The study aims to enroll a diverse population, including patients with resistant hypertension who are on three or more medications.\n\nIf you qualify and choose to participate, you will first complete a 2-week period taking a placebo to ensure you can follow the study requirements. Afterwards, you will be randomly assigned to take a once-daily pill for 12 weeks, which will be one of three different doses of the investigational drug RTN-001 or a matching placebo. The main purpose of the study is to see if RTN-001 can effectively lower systolic blood pressure. Throughout the study, you will attend several clinic visits (at weeks 2, 4, 8, and 12) for procedures that include blood pressure measurements in the office, wearing a 24-hour blood pressure monitor at home, blood tests, heart tracings (ECGs), and physical exams.",
                  "total_sites": 8,
                  "similarity_score": 0.8068209341486747
                },
                {
                  "id": 2,
                  "trial_name": "A Phase 3 Randomized, Double-blind, Multi-center, Placebo-controlled Study to Evaluate the Efficacy and Safety of AR882 in Participants with Gout",
                  "conditions": "Gout",
                  "description": "",
                  "investigator_name": "Dr. Patrick Dennis",
                  "site_location": "New Orleans, LA",
                  "protocol_summary": "The clinical trial, identified as Protocol AR882-301, is a Phase 3, randomized, double-blind, multi-center, placebo-controlled study designed to evaluate the efficacy and safety of the investigational drug AR882 in participants with gout. Sponsored by Arthrosi Therapeutics, Inc., this trial will be conducted across approximately 100 sites in the United States and Canada. The primary objective is to assess the ability of AR882 to reduce serum uric acid (sUA) levels in participants, with a specific focus on achieving sUA levels below 6.0 mg/dL by Month 6.\n\nParticipants in the trial will be randomly assigned to receive either AR882 or a placebo. The study will be double-blind, meaning neither the participants nor the investigators will know which treatment each participant is receiving. The intervention involves the administration of AR882, with the primary aim of evaluating its efficacy in lowering sUA levels and reducing tophus burden. The CAPER method will be employed to assess the response of target tophi, with evaluations conducted at Months 6 and 12 to determine the presence of disease progression.\n\nThe primary endpoint of the study is the proportion of participants achieving sUA levels below 6.0 mg/dL at Month 6. Secondary endpoints include the reduction of tophus burden and the maintenance of sUA levels below 6.0 mg/dL at Months 9 and 12, alongside the absence of gout flares over a three-month period. The trial will last until all participants have completed 12 months or have discontinued. Notable inclusion criteria include a diagnosis of gout and baseline tophi, while exclusion criteria may involve other significant health conditions that could interfere with the study's outcomes.",
                  "total_sites": 17,
                  "similarity_score": 0.8027487136996964
                },
                {
                  "id": 66,
                  "trial_name": "A Randomized, Double-blind, Multicenter, Colchicine and Placebo-controlled Study to Evaluate the Efficacy and Safety of ABP-745 in Subjects with an Acute Gout Flare",
                  "conditions": "Gout",
                  "description": "This is a Phase II, randomized, double-blind, placebo-controlled, multi-center study sponsored by Atom Therapeutics Co., Ltd.  The study will be conducted in the United States, Australia, and China and will last approximately 6 months for each participant, with the possibility of re-screening and continuing for another 6 months if no flare occurs in the initial period.  This means that neither you nor your doctor will know which treatment you are receiving, and participants will be randomly assigned to different treatment groups.  The study aims to determine how well ABP-745 works to treat acute gout flares compared to colchicine and a placebo.\n\nThis study is looking for men and women aged 18-70 with a BMI between 18 and 40 who have been diagnosed with gout and have experienced at least two gout flares in the past year.  You must be able to contact the study site and receive your first dose within 10 hours of a new flare starting, and you must be able to return to the site 24 hours after the first dose.  You will need to be able to attend several visits at the study site over a 7-day period during a flare and a final visit after treatment, as well as a safety follow-up phone call.  You may not be eligible to participate if you have certain other medical conditions or are taking certain medications.  Your doctor will discuss these criteria with you in more detail.\n\nParticipants will be randomly assigned to receive either ABP-745 (at one of two doses), colchicine, or a placebo.  The study will measure pain levels, tenderness, and swelling in your most affected joint.  The main goals are to see how much ABP-745 reduces pain at 24 hours after the first dose compared to colchicine and placebo.  Other measurements will include pain levels at later time points, the percentage of people who experience significant pain reduction, and how the treatment affects markers of inflammation in your blood.  You will take the study medication twice daily for 7 days during a flare.  You will have several visits to the study site during this time for assessments and blood draws.",
                  "investigator_name": "Dr. Patrick Dennis",
                  "site_location": "New Orleans, LA",
                  "protocol_summary": "This is a Phase II, randomized, double-blind, placebo-controlled, multi-center study sponsored by Atom Therapeutics Co., Ltd.  The study will be conducted in the United States, Australia, and China and will last approximately 6 months for each participant, with the possibility of re-screening and continuing for another 6 months if no flare occurs in the initial period.  This means that neither you nor your doctor will know which treatment you are receiving, and participants will be randomly assigned to different treatment groups.  The study aims to determine how well ABP-745 works to treat acute gout flares compared to colchicine and a placebo.\n\nThis study is looking for men and women aged 18-70 with a BMI between 18 and 40 who have been diagnosed with gout and have experienced at least two gout flares in the past year.  You must be able to contact the study site and receive your first dose within 10 hours of a new flare starting, and you must be able to return to the site 24 hours after the first dose.  You will need to be able to attend several visits at the study site over a 7-day period during a flare and a final visit after treatment, as well as a safety follow-up phone call.  You may not be eligible to participate if you have certain other medical conditions or are taking certain medications.  Your doctor will discuss these criteria with you in more detail.\n\nParticipants will be randomly assigned to receive either ABP-745 (at one of two doses), colchicine, or a placebo.  The study will measure pain levels, tenderness, and swelling in your most affected joint.  The main goals are to see how much ABP-745 reduces pain at 24 hours after the first dose compared to colchicine and placebo.  Other measurements will include pain levels at later time points, the percentage of people who experience significant pain reduction, and how the treatment affects markers of inflammation in your blood.  You will take the study medication twice daily for 7 days during a flare.  You will have several visits to the study site during this time for assessments and blood draws.",
                  "total_sites": 4,
                  "similarity_score": 0.7992400049183908
                }
              ],
              "semantic_search": true
            },
            "response_time": 21.277979850769043,
            "timestamp": "2025-12-16T07:45:27.383919"
          },
          {
            "user_message": "Yes, check my eligibility",
            "bot_response": "Great! I'll help you check your eligibility.\n\nI need to ask you a few questions about the hypertension trial.\n\n**Question 1 of 5:** What is your age?",
            "metadata": {
              "session_id": "AUTO_TEST_edge_age_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "start_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": "yes",
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "start_prescreening",
                "parameters": {},
                "response_text": "Of course. I can ask you a few questions to see if you might be a good fit for these trials. This is just a preliminary check, and the final decision is always made by the study team.\n\nTo start, could you please tell me your age?",
                "new_state": "prescreening",
                "collect_entities": [
                  "age"
                ],
                "metadata": {
                  "reasoning": "The user has explicitly agreed to an eligibility check after being shown a list of trials. The current state is 'trials_shown'. The most logical next step is to begin the prescreening process by asking the first common eligibility question, which is age. This action transitions the conversation into the 'prescreening' state and collects the necessary information to proceed."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "prescreening_started": true,
              "trial_id": 106,
              "trial_name": "A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Study of Modified Release RTN-001 In Patients with Uncontrolled Hypertension",
              "current_question_index": 0,
              "total_questions": 5,
              "current_question": "What is your age?",
              "expected_answer_type": "number"
            },
            "response_time": 20.925669193267822,
            "timestamp": "2025-12-16T07:45:48.317012"
          },
          {
            "user_message": "75",
            "bot_response": "Got it.\n\nAre you currently taking any medications related to your condition? If yes, would you be able to adjust them as needed for the trial?",
            "metadata": {
              "session_id": "AUTO_TEST_edge_age_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": 75,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {
                  "question_id": "other_conditions"
                },
                "response_text": "Thanks for sharing that. Next question: Have you been diagnosed with any other major health conditions, such as heart disease or diabetes?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "boolean_answer"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and has just provided their age in response to a question. The logical next step is to continue the prescreening process by asking the next relevant eligibility question. This question about other major health conditions is a common and important screening criterion for many trials, especially for hypertension. The state remains 'prescreening_active' as we are still in the middle of the eligibility check."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "current_question_index": 1,
              "total_questions": 5,
              "current_question": "Are you currently taking any medications related to your condition? If yes, would you be able to adjust them as needed for the trial?",
              "expected_answer_type": "text",
              "parsed_answer": {
                "interpretation": "number",
                "confidence": 1.0
              }
            },
            "response_time": 24.574378967285156,
            "timestamp": "2025-12-16T07:46:12.891880"
          },
          {
            "user_message": "Yes, I have Hypertension",
            "bot_response": "Thank you for that information.\n\nDo you meet the medical requirements needed to participate in this study?",
            "metadata": {
              "session_id": "AUTO_TEST_edge_age_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": "Hypertension",
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Got it, thank you for sharing. To continue checking your eligibility, could you please tell me the name of the medication you're currently taking for your hypertension?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "medication"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session and has answered the previous yes/no question, confirming they are taking medication. The logical next step is to ask a follow-up question to gather more specific information required for eligibility. Asking for the name of the medication is a standard next step in a hypertension trial prescreening. The state remains 'prescreening_active' as the process is not yet complete."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "current_question_index": 2,
              "total_questions": 5,
              "current_question": "Do you meet the medical requirements needed to participate in this study?",
              "expected_answer_type": "yes_no",
              "parsed_answer": {
                "interpretation": "text",
                "confidence": 1.0
              }
            },
            "response_time": 47.66013789176941,
            "timestamp": "2025-12-16T07:47:00.552578"
          },
          {
            "user_message": "Yes, I believe I do",
            "bot_response": "Thank you.\n\nWhat is your current BMI (Body Mass Index)?",
            "metadata": {
              "session_id": "AUTO_TEST_edge_age_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Okay, thank you for confirming. Just a couple more questions to go. Are you currently taking any medication for your hypertension?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "boolean_answer",
                  "medication"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session (state: prescreening_active) and has provided an affirmative answer to the previous question. The correct action is to continue the prescreening process by asking the next relevant eligibility question. This response acknowledges their answer, sets expectations ('a couple more questions'), and asks about current medications, which is a standard and logical next step for a hypertension trial prescreener. The state remains 'prescreening_active' as the process is not yet complete."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "current_question_index": 3,
              "total_questions": 5,
              "current_question": "What is your current BMI (Body Mass Index)?",
              "expected_answer_type": "text",
              "parsed_answer": {
                "interpretation": "yes",
                "confidence": 0.95
              }
            },
            "response_time": 24.26144790649414,
            "timestamp": "2025-12-16T07:47:24.815032"
          },
          {
            "user_message": "29.8",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_edge_age_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": 29.8,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {
                  "last_answer_provided": "29.8"
                },
                "response_text": "Thanks for sharing that. We're almost done. Do you have any other major health conditions, such as diabetes, heart disease, or kidney disease?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "boolean_answer"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and has provided a numerical answer (likely their BMI) to the previous question. The correct action is to continue the prescreening process by acknowledging their answer and asking the next relevant eligibility question. The chosen question about other major health conditions is a common and critical criterion for hypertension trials, and it naturally follows the flow of a medical screening."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 3
            },
            "response_time": 21.875730276107788,
            "timestamp": "2025-12-16T07:47:46.691586"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_edge_age_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Got it, thank you. The next question is about Body Mass Index (BMI), which is a common eligibility factor. Could you please share your height and weight?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and has provided a simple 'Yes' to the previous question. The correct action is to acknowledge their answer and proceed to the next question in the prescreening sequence. A logical next step for a hypertension trial is to collect height and weight to calculate BMI, a standard eligibility criterion. The state remains 'prescreening_active' as the process is not yet complete."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 3
            },
            "response_time": 25.162705898284912,
            "timestamp": "2025-12-16T07:48:11.854871"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_edge_age_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thanks for confirming. To move forward, could you please share your height and weight? This information helps us check some of the basic eligibility requirements for the trial.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and has responded with 'Yes' to a question that required specific information (height and weight). The user's response did not provide the necessary data. The best action is to continue the prescreening process by politely re-asking the question, clarifying why the information is needed. The state remains 'prescreening_active' as we are still trying to collect the same information to complete the current step."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 3
            },
            "response_time": 23.681972980499268,
            "timestamp": "2025-12-16T07:48:35.537425"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_edge_age_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "I appreciate the response! It seems I need a bit more specific information for this question. Could you please provide your height and weight? For example, you can say '5 feet 10 inches, 180 pounds'.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and provided a boolean 'Yes' which is not a valid answer to the likely previous question (e.g., asking for height/weight). The best action is to continue the prescreening by politely re-asking the question with a clear example of the expected format to guide the user and collect the necessary information to proceed. The state remains 'prescreening_active' as we are retrying the current step."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 3
            },
            "response_time": 53.45372128486633,
            "timestamp": "2025-12-16T07:49:28.991576"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_edge_age_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thanks for your response. My apologies if my last question was unclear. To continue with the next step, I'll need your height and weight. This is often used to calculate Body Mass Index (BMI), which is a common eligibility requirement. Could you please provide that for me?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state but provided a boolean answer ('Yes') to a question that, based on the context, required their height and weight. The user's response does not satisfy the previous prompt. The best action is to continue the prescreening by gently re-prompting for the necessary information, explaining its relevance (BMI) to guide the user back on track. This maintains the conversation flow and helps the user provide the correct data to proceed with the eligibility check."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 3
            },
            "response_time": 42.41555094718933,
            "timestamp": "2025-12-16T07:50:11.407970"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_edge_age_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Great! To continue with the prescreening, could you please tell me your height and weight? This information is often used to check for criteria like Body Mass Index (BMI).",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session and has responded affirmatively ('Yes'), likely confirming their willingness to answer the next question. The best action is to continue the prescreening process by explicitly asking for the required information (height and weight). The response is encouraging, provides context on why the information is needed (for BMI), and guides the user on what to provide next, keeping the conversation moving forward smoothly."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 3
            },
            "response_time": 56.123883962631226,
            "timestamp": "2025-12-16T07:51:07.532683"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_edge_age_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Great! To continue with the prescreening, could you please tell me your height and weight? This information is often important for determining eligibility.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state. Their 'Yes' response did not directly answer the previous question, which, based on the context, was likely a request for specific information like height and weight. The best course of action is to gently re-prompt for the required information to keep the prescreening process moving forward smoothly. This approach acknowledges their input while clarifying what is needed next in a supportive manner."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 3
            },
            "response_time": 40.0849711894989,
            "timestamp": "2025-12-16T07:51:47.619187"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_edge_age_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Got it, thanks for confirming. Just a couple more questions to go. Have you participated in any other clinical research study within the last 30 days?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "boolean_answer"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening flow (state: prescreening_active) and has just provided a 'Yes' answer to the previous question. The correct action is to acknowledge their response and proceed with the next question in the prescreening sequence. The chosen question about participation in other recent trials is a standard exclusion criterion and a logical next step. The state remains 'prescreening_active' as the process is ongoing."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 3
            },
            "response_time": 21.352458953857422,
            "timestamp": "2025-12-16T07:52:08.972346"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_edge_age_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thanks for confirming. To continue, I'll need your height and weight. This information helps determine your Body Mass Index (BMI), which is often part of the eligibility criteria. Could you please provide those details?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and provided a boolean 'Yes' which is not a valid answer to the likely previous question about height and weight. The best action is to continue the prescreening by gently re-prompting for the required information, explaining why it's needed (for BMI calculation), and maintaining a supportive tone. This keeps the conversation on track without making the user feel they made an error."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 3
            },
            "response_time": 40.93455791473389,
            "timestamp": "2025-12-16T07:52:49.908023"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_edge_age_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {
                  "reprompt": true,
                  "invalid_answer": "Yes"
                },
                "response_text": "I appreciate the response! My apologies, I should have been more specific. To check this next eligibility requirement, I'll need your current height and weight. Could you please provide them for me? For example, '5'10\", 180 lbs'.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and provided a boolean 'Yes' answer, which is not a valid response to the likely previous question about height and weight. The best action is to continue the prescreening by politely re-asking the question with more clarity and providing an example format. This keeps the user engaged and helps them provide the necessary information to move forward."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 3
            },
            "response_time": 54.665802001953125,
            "timestamp": "2025-12-16T07:53:44.574837"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_edge_age_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "I appreciate you getting back to me. My last question was about your height and weight, which is often used to determine eligibility. Could you please provide those details when you have a moment?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session and has provided a simple 'Yes' response. The OpenAI reasoning correctly identifies that this is not a valid answer to the likely previous question about height and weight. The best course of action is to continue the prescreening by gently re-prompting for the necessary information. The response clarifies what is needed and why, maintaining a helpful and conversational tone. The state remains 'prescreening_active' as the process is not yet complete."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 3
            },
            "response_time": 24.878352880477905,
            "timestamp": "2025-12-16T07:54:09.453724"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_edge_age_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Great, thanks for confirming. To move forward, could you please tell me your height and weight? This information is often used to calculate Body Mass Index (BMI), which is a common factor in determining eligibility for hypertension studies.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and responded with 'Yes'. Based on the provided reasoning that the previous question likely asked for height and weight, this 'Yes' does not fulfill the information requirement. The best action is to continue the prescreening by gently re-asking for the specific information needed (height and weight) and providing context on why it's necessary (for BMI calculation). This keeps the conversation moving forward constructively while maintaining a supportive tone."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 3
            },
            "response_time": 21.710768699645996,
            "timestamp": "2025-12-16T07:54:31.164870"
          },
          {
            "user_message": "Yes",
            "bot_response": "I'm here to help you find clinical trials. What condition are you interested in?",
            "metadata": {
              "session_id": "AUTO_TEST_edge_age_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "general_response",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "general_response",
                "parameters": {},
                "response_text": "I'm here to help you find clinical trials. What condition are you interested in?",
                "new_state": "initial",
                "collect_entities": null,
                "metadata": {
                  "fallback": true
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "general_response": true
            },
            "response_time": 56.23612093925476,
            "timestamp": "2025-12-16T07:55:27.401452"
          },
          {
            "user_message": "Yes, I have Hypertension",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_edge_age_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": "Hypertension",
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {
                  "question_id": "q2_age",
                  "question_text": "Are you over 18 years old?"
                },
                "response_text": "Okay, thank you for confirming that. Just a couple more questions to check the basic requirements. Are you over 18 years old?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "boolean_answer",
                  "age"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening flow and has just answered a question confirming their condition. The correct action is to continue the prescreening process by acknowledging their answer and asking the next logical eligibility question. The state remains 'prescreening_active' as the process is not yet complete."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 3
            },
            "response_time": 29.332343101501465,
            "timestamp": "2025-12-16T07:55:56.734322"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_edge_age_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thanks. To continue with the eligibility check, I'll need your height and weight. Could you please provide that information for me?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and responded with 'Yes'. According to the provided reasoning, this does not answer the previous question which required height and weight. The most appropriate action is to continue the prescreening process by gently re-prompting for the specific information needed. This clarifies the request, keeps the user engaged in the eligibility check, and maintains the current conversation state."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 3
            },
            "response_time": 25.53006100654602,
            "timestamp": "2025-12-16T07:56:22.265276"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_edge_age_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thanks for confirming. Could you please share your height and weight? This information is often used to calculate Body Mass Index (BMI), which is a common factor in determining eligibility.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and responded with 'Yes' to a question that likely required specific information (height and weight). This action acknowledges their affirmative response while gently re-prompting for the necessary data. It explains why the information is needed (for BMI calculation), which is helpful and transparent. The state remains 'prescreening_active' as we are continuing the same process, and we need to collect height and weight from the next user message."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 3
            },
            "response_time": 57.07706332206726,
            "timestamp": "2025-12-16T07:57:19.342825"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_edge_age_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Great! To move forward, I'll need your current height and weight. This is just to check the Body Mass Index (BMI) requirement for the study. How tall are you and how much do you weigh?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and responded with 'Yes'. The previous turn likely asked for height and weight, which this response does not provide. The best action is to continue the prescreening by gently re-prompting for the required information (height and weight) to move forward with the eligibility check. The response acknowledges their confirmation and clearly states the next required information and why it's needed, which is helpful and transparent."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 3
            },
            "response_time": 37.75145864486694,
            "timestamp": "2025-12-16T07:57:57.094885"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_edge_age_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Great! Could you please tell me your height and weight? This information is often used to calculate Body Mass Index (BMI), which can be an important factor for eligibility in some studies.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and has responded affirmatively ('Yes') to the presumed previous question about their willingness to provide height and weight. The most logical next step is to continue the prescreening flow by directly asking for this information. The response explains why the information is needed (for BMI calculation), which is helpful and transparent, maintaining a supportive tone. The state remains 'prescreening_active' as we are still in the process of gathering eligibility information."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 3
            },
            "response_time": 36.63349986076355,
            "timestamp": "2025-12-16T07:58:33.731907"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_edge_age_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "My apologies, I wasn't quite clear. To check this eligibility criterion, I'll need your height and weight. For example, you could tell me '5 feet 9 inches, 175 pounds'.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening flow (state: prescreening_active) and provided a 'Yes' response. Based on the OpenAI reasoning, this is an invalid answer to the previous question which likely asked for height and weight. The best action is to continue the prescreening by politely re-asking the question with a clear example to guide the user. This keeps the conversation on track without making the user feel they made an error. The state remains 'prescreening_active' as we are still on the same step."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 3
            },
            "response_time": 55.01471400260925,
            "timestamp": "2025-12-16T07:59:28.747153"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_edge_age_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {
                  "next_question": "height_and_weight"
                },
                "response_text": "Great. Could you please tell me your height and weight? This information is often used to calculate Body Mass Index (BMI), which can be an important eligibility factor for hypertension studies.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session and has provided a 'Yes' response, likely confirming their willingness to proceed or answer the next question. The NLU reasoning suggests the next required information is height and weight. Therefore, the best action is to continue the prescreening process by explicitly asking for this information. The response is designed to be clear, explain the reason for the question (BMI calculation), and smoothly guide the user to the next step."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 3
            },
            "response_time": 21.85316300392151,
            "timestamp": "2025-12-16T07:59:50.601235"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_edge_age_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Great. Could you please tell me your height and weight? We need this to calculate your Body Mass Index (BMI), which is a common eligibility criterion for many trials.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and has responded with a simple 'Yes', likely affirming their willingness to continue. The previous turn probably set up the next question. The most logical next step is to proceed by asking the next prescreening question, which, based on the provided reasoning, is to collect height and weight to calculate BMI. This action directly continues the established flow and moves the user closer to completing the eligibility check."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 3
            },
            "response_time": 24.80805015563965,
            "timestamp": "2025-12-16T08:00:15.410061"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_edge_age_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thanks for confirming you'd like to continue. To proceed with the next step, could you please provide your height and weight? This information is often used to calculate Body Mass Index (BMI) as part of the eligibility criteria.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and responded with 'Yes' to a question that likely required specific information (height and weight, based on the OpenAI reasoning). This response doesn't provide the necessary data. The best action is to continue the prescreening by gently re-asking the question, explaining why the information is needed, and setting the expectation to collect height and weight from the next user message. The state remains 'prescreening_active' as we haven't successfully completed the current step."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 3
            },
            "response_time": 24.117200136184692,
            "timestamp": "2025-12-16T08:00:39.527839"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_edge_age_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Thanks! To continue with the eligibility check, could you please provide your height and weight? This is often used to calculate Body Mass Index (BMI), which is a common requirement for hypertension studies.",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening session and provided a non-informative 'Yes' in response to what was likely a question requesting specific information (height and weight, based on the OpenAI reasoning). The user's intent is to continue, but their response did not provide the necessary data. The best action is to continue the prescreening flow by gently re-asking the question, providing helpful context on why this information is needed (for BMI calculation). This keeps the conversation on track and guides the user to provide the required details, maintaining a supportive and helpful tone."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 3
            },
            "response_time": 23.079675912857056,
            "timestamp": "2025-12-16T08:01:02.608048"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_edge_age_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Got it. To make sure this trial is a good fit, I'll need your specific height and weight. This information helps determine eligibility, often by calculating Body Mass Index (BMI). Could you please provide your height and weight?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and provided a non-compliant 'Yes' answer to a question that requires specific information (likely height and weight, based on the OpenAI reasoning). The best action is to continue the prescreening by gently re-prompting for the necessary details, explaining why they are needed (for BMI calculation), and maintaining a helpful tone. The state remains `prescreening_active` as we are re-asking the current question."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 3
            },
            "response_time": 25.439945220947266,
            "timestamp": "2025-12-16T08:01:28.048651"
          },
          {
            "user_message": "Yes",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_edge_age_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "I understand. To check this next eligibility requirement, I'll need your height and weight. Could you please provide that information?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "height",
                  "weight"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening flow and provided a 'Yes' response to a question that required specific information (height and weight). This action re-prompts the user for the necessary information to continue the prescreening process, keeping the conversation on track while maintaining a helpful tone. The state remains 'prescreening_active' as the flow is not yet complete."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 3
            },
            "response_time": 21.820560932159424,
            "timestamp": "2025-12-16T08:01:49.870007"
          },
          {
            "user_message": "Yes",
            "bot_response": "I'm here to help you find clinical trials. What condition are you interested in?",
            "metadata": {
              "session_id": "AUTO_TEST_edge_age_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "general_response",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "general_response",
                "parameters": {},
                "response_text": "I'm here to help you find clinical trials. What condition are you interested in?",
                "new_state": "initial",
                "collect_entities": null,
                "metadata": {
                  "fallback": true
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "general_response": true
            },
            "response_time": 58.63143801689148,
            "timestamp": "2025-12-16T08:02:48.502314"
          },
          {
            "user_message": "Yes, I have Hypertension",
            "bot_response": "I couldn't find height and weight information in your response. Could you please provide both your height and weight together?\n\nExamples:\n\u2022 '6 feet 2 inches, 180 pounds'\n\u2022 '6'0\", 215 lbs'\n\u2022 '6 foot 5, 200 pounds'",
            "metadata": {
              "session_id": "AUTO_TEST_edge_age_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": "Hypertension",
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {
                  "last_answer": "User confirmed they have Hypertension."
                },
                "response_text": "Okay, thank you for confirming. The next question is: are you currently taking any medications to manage your hypertension?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "medication",
                  "boolean_answer"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening flow and has just answered a question confirming their condition. The most appropriate action is to continue the prescreening process by acknowledging their answer and asking the next logical eligibility question. The state remains 'prescreening_active' as the check is not yet complete."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "validation_error": true,
              "awaiting_correction": true,
              "current_question_index": 3
            },
            "response_time": 23.210429906845093,
            "timestamp": "2025-12-16T08:03:11.713284"
          }
        ],
        "final_state": "completed",
        "total_turns": 32,
        "total_questions_asked": 5,
        "errors": [
          {
            "type": "too_many_turns",
            "turns_processed": 30
          }
        ]
      },
      "validation": {
        "passed": false,
        "overall_score": 50.0,
        "crash_prevention": {
          "passed": true,
          "score": 100.0,
          "error_count": 0,
          "errors": [],
          "failures": []
        },
        "eligibility_accuracy": {
          "passed": false,
          "score": 0.0,
          "reason": "Could not extract eligibility result",
          "failures": [
            {
              "type": "eligibility_logic_error",
              "reason": "No eligibility determination found in conversation",
              "likely_location": "core/prescreening/gemini_prescreening_manager.py:evaluate_eligibility()",
              "severity": "high"
            }
          ]
        },
        "conversation_quality": {
          "passed": false,
          "score": 0.0,
          "total_questions_asked": 5,
          "issues": [
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I couldn't find height and weight information in y...",
            "Repeated question: I'm here to help you find clinical trials. What co...",
            "Repeated question: I couldn't find height and weight information in y..."
          ],
          "failures": [
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I'm here to help you find clinical trials. What co...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            },
            {
              "type": "conversation_quality_issue",
              "issue": "Repeated question: I couldn't find height and weight information in y...",
              "severity": "medium",
              "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
            }
          ]
        },
        "edge_case_handling": {
          "passed": true,
          "score": 100.0,
          "applicable": true,
          "edge_case_type": "extreme_age",
          "completed": true,
          "failures": []
        },
        "performance": {
          "passed": false,
          "score": 40.0,
          "avg_response_time": 33.924244217574596,
          "max_response_time": 58.63143801689148,
          "status": "slow",
          "failures": [
            {
              "type": "performance_issue",
              "avg_response_time": 33.924244217574596,
              "max_response_time": 58.63143801689148,
              "severity": "low",
              "recommendation": "Investigate slow API responses or Gemini API delays"
            }
          ]
        },
        "failure_points": [
          {
            "type": "eligibility_logic_error",
            "reason": "No eligibility determination found in conversation",
            "likely_location": "core/prescreening/gemini_prescreening_manager.py:evaluate_eligibility()",
            "severity": "high"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I'm here to help you find clinical trials. What co...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "conversation_quality_issue",
            "issue": "Repeated question: I couldn't find height and weight information in y...",
            "severity": "medium",
            "likely_location": "core/conversation/gemini_conversation_manager.py or core/prescreening/gemini_prescreening_manager.py"
          },
          {
            "type": "performance_issue",
            "avg_response_time": 33.924244217574596,
            "max_response_time": 58.63143801689148,
            "severity": "low",
            "recommendation": "Investigate slow API responses or Gemini API delays"
          }
        ],
        "recommendations": [
          "\u26a0\ufe0f HIGH: Review eligibility evaluation logic in gemini_prescreening_manager.py",
          "\u26a0\ufe0f MEDIUM: Major conversation quality issues. Review question generation and response handling.",
          "\u2139\ufe0f LOW: Slow response times. Optimize API calls or consider caching."
        ]
      },
      "timestamp": "2025-12-16T08:03:11.714104"
    },
    {
      "patient_id": "AUTO_TEST_random_000",
      "patient_profile": {
        "patient_id": "AUTO_TEST_random_000",
        "profile_type": "random",
        "demographics": {
          "age": 69,
          "gender": "female",
          "location": "Baton Rouge, LA",
          "name": "Jennifer Jones",
          "first_name": "Jennifer",
          "last_name": "Jones"
        },
        "medical_history": {
          "primary_condition": "Osteoarthritis of the Knee",
          "conditions": [
            "Osteoarthritis of the Knee"
          ],
          "medications": [
            "Cortisone Injections",
            "Acetaminophen",
            "NSAIDs"
          ],
          "duration_years": 1
        },
        "expected_behavior": {
          "should_find_trials": true,
          "likely_eligible": true,
          "expected_question_count_range": [
            4,
            8
          ]
        }
      },
      "conversation_result": {
        "session_id": "AUTO_TEST_random_000",
        "patient_id": "AUTO_TEST_random_000",
        "conversation_log": [
          {
            "user_message": "Osteoarthritis of the Knee trials in Baton Rouge, LA",
            "bot_response": "Great! I found 5 clinical trial(s) available in Baton Rouge, LA:\n\n**Dr. Ira Thorla**\n  \u2022 Female Pattern Hair Loss (Androgenetic Alopecia) (1 trial)\n\n**Dr. Taylor Sanders**\n  \u2022 Gout (2 trials)\n  \u2022 COVID-19 (1 trial)\n  \u2022 Fibromyalgia (1 trial)\n\nWould you like to:\n1. Check your eligibility for any of these trials?\n2. Learn more about a specific condition?\n3. See trials in a different location?",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "trials_shown",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "search_trials",
              "entities_collected": {
                "condition": "Osteoarthritis of the Knee",
                "location": "Baton Rouge",
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "search_trials",
                "parameters": {
                  "condition": "Osteoarthritis of the Knee",
                  "location": "Baton Rouge, LA"
                },
                "response_text": "Of course, I can help with that. Let me switch gears and look for clinical trials for Osteoarthritis of the Knee in the Baton Rouge area for you now.",
                "new_state": "trials_found",
                "collect_entities": [],
                "metadata": {
                  "reasoning": "The user has provided a new, complete search request with both a condition ('Osteoarthritis of the Knee') and a location ('Baton Rouge, LA'). This is a context switch from the previous conversation about Type 2 Diabetes. The best action is to acknowledge the new request and perform the search. The response confirms the new search parameters and informs the user that I am proceeding with their request, ensuring a smooth transition."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "trials_found": 5,
              "condition": "Osteoarthritis of the Knee",
              "location": "Baton Rouge, LA",
              "trials_data": [
                {
                  "id": 14,
                  "trial_name": "Clinical Trial 250-13951-306",
                  "conditions": "Female Pattern Hair Loss (Androgenetic Alopecia)",
                  "description": null,
                  "investigator_name": "Dr. Ira Thorla",
                  "site_location": "Baton Rouge, LA",
                  "protocol_summary": "This clinical trial aims to investigate the effectiveness and safety of an oral medication called VDPHL01 for treating female pattern hair loss (androgenetic alopecia).  The study will evaluate two different dosing regimens of VDPHL01: twice daily and once daily.  It will compare these regimens against a placebo to see if the medication promotes hair growth and improves patient satisfaction with their hair.\n\nWomen aged 18-65 with mild to moderate hair loss, as measured by the Savin Scale, are eligible to participate.  Key inclusion criteria include good general health, adequate kidney and liver function, and a commitment to maintaining consistent hair care routines throughout the study.  Women who are pregnant, breastfeeding, have certain medical conditions (like uncontrolled blood pressure or a history of heart problems), or have recently used other hair growth treatments are excluded.\n\nThe study will last approximately 13 months and consist of two parts. Part A is a 6-month placebo-controlled period, where participants are randomly assigned to one of four groups: VDPHL01 twice daily, VDPHL01 once daily plus placebo, placebo twice daily, or placebo twice daily.  Part B is a 6-month treatment extension, where those initially receiving placebo will start taking VDPHL01 according to their initial group assignment, while those already on VDPHL01 will continue.  Participants will have regular clinic visits (approximately 11) for assessments including physical exams, blood and urine tests, electrocardiograms, photographs of the scalp, and questionnaires about their hair and quality of life. A small group of participants will also take part in interviews.  A final follow-up will occur one month after the treatment period ends.\n",
                  "total_sites": 2,
                  "similarity_score": 0.7818238559465687
                },
                {
                  "id": 2,
                  "trial_name": "A Phase 3 Randomized, Double-blind, Multi-center, Placebo-controlled Study to Evaluate the Efficacy and Safety of AR882 in Participants with Gout",
                  "conditions": "Gout",
                  "description": "",
                  "investigator_name": "Dr. Taylor Sanders",
                  "site_location": "Baton Rouge, LA",
                  "protocol_summary": "The clinical trial, identified as Protocol AR882-301, is a Phase 3, randomized, double-blind, multi-center, placebo-controlled study designed to evaluate the efficacy and safety of the investigational drug AR882 in participants with gout. Sponsored by Arthrosi Therapeutics, Inc., this trial will be conducted across approximately 100 sites in the United States and Canada. The primary objective is to assess the ability of AR882 to reduce serum uric acid (sUA) levels in participants, with a specific focus on achieving sUA levels below 6.0 mg/dL by Month 6.\n\nParticipants in the trial will be randomly assigned to receive either AR882 or a placebo. The study will be double-blind, meaning neither the participants nor the investigators will know which treatment each participant is receiving. The intervention involves the administration of AR882, with the primary aim of evaluating its efficacy in lowering sUA levels and reducing tophus burden. The CAPER method will be employed to assess the response of target tophi, with evaluations conducted at Months 6 and 12 to determine the presence of disease progression.\n\nThe primary endpoint of the study is the proportion of participants achieving sUA levels below 6.0 mg/dL at Month 6. Secondary endpoints include the reduction of tophus burden and the maintenance of sUA levels below 6.0 mg/dL at Months 9 and 12, alongside the absence of gout flares over a three-month period. The trial will last until all participants have completed 12 months or have discontinued. Notable inclusion criteria include a diagnosis of gout and baseline tophi, while exclusion criteria may involve other significant health conditions that could interfere with the study's outcomes.",
                  "total_sites": 17,
                  "similarity_score": 0.7596899954635156
                },
                {
                  "id": 66,
                  "trial_name": "A Randomized, Double-blind, Multicenter, Colchicine and Placebo-controlled Study to Evaluate the Efficacy and Safety of ABP-745 in Subjects with an Acute Gout Flare",
                  "conditions": "Gout",
                  "description": "This is a Phase II, randomized, double-blind, placebo-controlled, multi-center study sponsored by Atom Therapeutics Co., Ltd.  The study will be conducted in the United States, Australia, and China and will last approximately 6 months for each participant, with the possibility of re-screening and continuing for another 6 months if no flare occurs in the initial period.  This means that neither you nor your doctor will know which treatment you are receiving, and participants will be randomly assigned to different treatment groups.  The study aims to determine how well ABP-745 works to treat acute gout flares compared to colchicine and a placebo.\n\nThis study is looking for men and women aged 18-70 with a BMI between 18 and 40 who have been diagnosed with gout and have experienced at least two gout flares in the past year.  You must be able to contact the study site and receive your first dose within 10 hours of a new flare starting, and you must be able to return to the site 24 hours after the first dose.  You will need to be able to attend several visits at the study site over a 7-day period during a flare and a final visit after treatment, as well as a safety follow-up phone call.  You may not be eligible to participate if you have certain other medical conditions or are taking certain medications.  Your doctor will discuss these criteria with you in more detail.\n\nParticipants will be randomly assigned to receive either ABP-745 (at one of two doses), colchicine, or a placebo.  The study will measure pain levels, tenderness, and swelling in your most affected joint.  The main goals are to see how much ABP-745 reduces pain at 24 hours after the first dose compared to colchicine and placebo.  Other measurements will include pain levels at later time points, the percentage of people who experience significant pain reduction, and how the treatment affects markers of inflammation in your blood.  You will take the study medication twice daily for 7 days during a flare.  You will have several visits to the study site during this time for assessments and blood draws.",
                  "investigator_name": "Dr. Taylor Sanders",
                  "site_location": "Baton Rouge, LA",
                  "protocol_summary": "This is a Phase II, randomized, double-blind, placebo-controlled, multi-center study sponsored by Atom Therapeutics Co., Ltd.  The study will be conducted in the United States, Australia, and China and will last approximately 6 months for each participant, with the possibility of re-screening and continuing for another 6 months if no flare occurs in the initial period.  This means that neither you nor your doctor will know which treatment you are receiving, and participants will be randomly assigned to different treatment groups.  The study aims to determine how well ABP-745 works to treat acute gout flares compared to colchicine and a placebo.\n\nThis study is looking for men and women aged 18-70 with a BMI between 18 and 40 who have been diagnosed with gout and have experienced at least two gout flares in the past year.  You must be able to contact the study site and receive your first dose within 10 hours of a new flare starting, and you must be able to return to the site 24 hours after the first dose.  You will need to be able to attend several visits at the study site over a 7-day period during a flare and a final visit after treatment, as well as a safety follow-up phone call.  You may not be eligible to participate if you have certain other medical conditions or are taking certain medications.  Your doctor will discuss these criteria with you in more detail.\n\nParticipants will be randomly assigned to receive either ABP-745 (at one of two doses), colchicine, or a placebo.  The study will measure pain levels, tenderness, and swelling in your most affected joint.  The main goals are to see how much ABP-745 reduces pain at 24 hours after the first dose compared to colchicine and placebo.  Other measurements will include pain levels at later time points, the percentage of people who experience significant pain reduction, and how the treatment affects markers of inflammation in your blood.  You will take the study medication twice daily for 7 days during a flare.  You will have several visits to the study site during this time for assessments and blood draws.",
                  "total_sites": 4,
                  "similarity_score": 0.7468033202522509
                }
              ],
              "semantic_search": true
            },
            "response_time": 23.97731924057007,
            "timestamp": "2025-12-16T08:03:35.692334"
          },
          {
            "user_message": "Yes, check my eligibility",
            "bot_response": "Great! I'll help you check your eligibility.\n\nI need to ask you a few questions about the osteoarthritis of the knee trial.\n\n**Question 1 of 4:** What is your age?",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "start_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "start_prescreening",
                "parameters": {},
                "response_text": "Great, I can help with that. I'll ask a few questions to see if you might be a match for any of these studies. To start, could you please tell me your age?",
                "new_state": "prescreening",
                "collect_entities": [
                  "age"
                ],
                "metadata": {
                  "reasoning": "The user has explicitly confirmed they want to check their eligibility after being shown a list of trials. The current state is 'trials_shown', making 'start_prescreening' the correct next action. The response confirms the user's request, sets expectations for the prescreening process, and asks the first common eligibility question (age) to move the conversation forward. The state is transitioned to 'prescreening' to reflect this new phase of the conversation."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "prescreening_started": true,
              "trial_id": 14,
              "trial_name": "Clinical Trial 250-13951-306",
              "current_question_index": 0,
              "total_questions": 4,
              "current_question": "What is your age?",
              "expected_answer_type": "number"
            },
            "response_time": 21.247554063796997,
            "timestamp": "2025-12-16T08:03:56.940909"
          },
          {
            "user_message": "69",
            "bot_response": "Got it.\n\nHave you been diagnosed with mild to moderate aga with a score of i-4 by a doctor?",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": 69,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": null,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {
                  "last_answer": "69"
                },
                "response_text": "Great, thank you. Just a couple more questions. Have you been diagnosed with osteoarthritis of the knee for at least 6 months?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "boolean_answer"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening state and has just provided their age in response to a direct question. The correct action is to acknowledge their answer and proceed with the next question in the prescreening flow. The next question is a common eligibility criterion for osteoarthritis trials (duration of diagnosis) and is phrased as a simple yes/no question to keep the conversation moving smoothly. The state remains 'prescreening_active' as the process is not yet complete."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "current_question_index": 1,
              "total_questions": 4,
              "current_question": "Have you been diagnosed with mild to moderate aga with a score of i-4 by a doctor?",
              "expected_answer_type": "yes_no",
              "parsed_answer": {
                "interpretation": "number",
                "confidence": 1.0
              }
            },
            "response_time": 24.09037685394287,
            "timestamp": "2025-12-16T08:04:21.031705"
          },
          {
            "user_message": "Yes, I have Osteoarthritis of the Knee",
            "bot_response": "Thank you for that information.\n\nDo you meet the medical requirements needed to participate in this study?",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": "Osteoarthritis of the Knee",
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": "yes",
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Great, thank you for confirming. The next question is: Have you had a total knee replacement on the knee with osteoarthritis?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "boolean_answer"
                ],
                "metadata": {
                  "reasoning": "The user has confirmed their condition in response to the previous prescreening question. The current state is `prescreening_active`, so the correct action is to proceed with the next question in the eligibility screener to continue assessing their fit for the trial. The chosen question about prior knee replacement surgery is a common and critical eligibility criterion for osteoarthritis trials."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "current_question_index": 2,
              "total_questions": 4,
              "current_question": "Do you meet the medical requirements needed to participate in this study?",
              "expected_answer_type": "yes_no",
              "parsed_answer": {
                "interpretation": "unclear",
                "confidence": 0.9
              }
            },
            "response_time": 39.2679340839386,
            "timestamp": "2025-12-16T08:05:00.300329"
          },
          {
            "user_message": "Yes, I believe I do",
            "bot_response": "Thank you.\n\nHave you been diagnosed with cancer within the past 5 years (excluding successfully treated skin cancer)?",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "prescreening_active",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": null,
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Okay, thank you for confirming. Just a couple more questions to go. Have you had any knee replacement surgery on the affected knee?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "boolean_answer"
                ],
                "metadata": {
                  "reasoning": "The user is actively engaged in the prescreening process and has just answered the previous question with 'Yes'. The current state is 'prescreening_active', so the most logical and helpful next step is to continue with the next question in the screening flow to move them closer to determining their potential eligibility."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "current_question_index": 3,
              "total_questions": 4,
              "current_question": "Have you been diagnosed with cancer within the past 5 years (excluding successfully treated skin cancer)?",
              "expected_answer_type": "yes_no",
              "parsed_answer": {
                "interpretation": "yes",
                "confidence": 1.0
              }
            },
            "response_time": 19.73178720474243,
            "timestamp": "2025-12-16T08:05:20.032841"
          },
          {
            "user_message": "Yes, I have Osteoarthritis of the Knee",
            "bot_response": "Thanks for completing the prescreening! I have a few questions that need clarification:\n\n\u2713 Age: 69\n\u2713 Medical history: Yes\n\u2713 Current condition: Yes\n? Medical history: Yes, I have Osteoarthritis of the Knee - needs clarification\n\nWould you like to:\n1. Continue with your current answers\n2. Update any responses\n\nPlease respond with '1' to continue or '2' to make changes.",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "prescreening_review",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": "Osteoarthritis of the Knee",
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Great, thanks for confirming. The next question is: Have you previously been treated with steroid injections for your knee pain?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "boolean_answer"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening flow (state: prescreening_active) and has just answered the previous question with 'Yes'. The most appropriate action is to acknowledge their answer and proceed with the next question in the prescreening sequence. This moves the user closer to determining their eligibility for the trial. The state remains 'prescreening_active' as the process is ongoing."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "pending_evaluation": true,
              "eligibility_result": "<coroutine object GeminiPrescreeningManager.evaluate_eligibility at 0x7fcc563114d0>",
              "summary": "\u2713 Age: 69\n\u2713 Medical history: Yes\n\u2713 Current condition: Yes\n? Medical history: Yes, I have Osteoarthritis of the Knee - needs clarification"
            },
            "response_time": 58.95304012298584,
            "timestamp": "2025-12-16T08:06:18.986410"
          },
          {
            "user_message": "Yes, everything is correct. Please continue with the eligibility evaluation.",
            "bot_response": "Please respond with '1' to continue with the current evaluation or '2' to make changes to your responses.",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "prescreening_review",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": "Osteoarthritis of the Knee",
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Great, thanks for confirming. The next question is: Have you previously been treated with steroid injections for your knee pain?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "boolean_answer"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening flow (state: prescreening_active) and has just answered the previous question with 'Yes'. The most appropriate action is to acknowledge their answer and proceed with the next question in the prescreening sequence. This moves the user closer to determining their eligibility for the trial. The state remains 'prescreening_active' as the process is ongoing."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "location": "Baton Rouge, LA",
              "condition": "Osteoarthritis of the Knee",
              "trials_data": [
                {
                  "id": 14,
                  "trial_name": "Clinical Trial 250-13951-306",
                  "conditions": "Female Pattern Hair Loss (Androgenetic Alopecia)",
                  "description": null,
                  "investigator_name": "Dr. Ira Thorla",
                  "site_location": "Baton Rouge, LA",
                  "protocol_summary": "This clinical trial aims to investigate the effectiveness and safety of an oral medication called VDPHL01 for treating female pattern hair loss (androgenetic alopecia).  The study will evaluate two different dosing regimens of VDPHL01: twice daily and once daily.  It will compare these regimens against a placebo to see if the medication promotes hair growth and improves patient satisfaction with their hair.\n\nWomen aged 18-65 with mild to moderate hair loss, as measured by the Savin Scale, are eligible to participate.  Key inclusion criteria include good general health, adequate kidney and liver function, and a commitment to maintaining consistent hair care routines throughout the study.  Women who are pregnant, breastfeeding, have certain medical conditions (like uncontrolled blood pressure or a history of heart problems), or have recently used other hair growth treatments are excluded.\n\nThe study will last approximately 13 months and consist of two parts. Part A is a 6-month placebo-controlled period, where participants are randomly assigned to one of four groups: VDPHL01 twice daily, VDPHL01 once daily plus placebo, placebo twice daily, or placebo twice daily.  Part B is a 6-month treatment extension, where those initially receiving placebo will start taking VDPHL01 according to their initial group assignment, while those already on VDPHL01 will continue.  Participants will have regular clinic visits (approximately 11) for assessments including physical exams, blood and urine tests, electrocardiograms, photographs of the scalp, and questionnaires about their hair and quality of life. A small group of participants will also take part in interviews.  A final follow-up will occur one month after the treatment period ends.\n",
                  "total_sites": 2,
                  "similarity_score": 0.7818238559465687
                },
                {
                  "id": 2,
                  "trial_name": "A Phase 3 Randomized, Double-blind, Multi-center, Placebo-controlled Study to Evaluate the Efficacy and Safety of AR882 in Participants with Gout",
                  "conditions": "Gout",
                  "description": "",
                  "investigator_name": "Dr. Taylor Sanders",
                  "site_location": "Baton Rouge, LA",
                  "protocol_summary": "The clinical trial, identified as Protocol AR882-301, is a Phase 3, randomized, double-blind, multi-center, placebo-controlled study designed to evaluate the efficacy and safety of the investigational drug AR882 in participants with gout. Sponsored by Arthrosi Therapeutics, Inc., this trial will be conducted across approximately 100 sites in the United States and Canada. The primary objective is to assess the ability of AR882 to reduce serum uric acid (sUA) levels in participants, with a specific focus on achieving sUA levels below 6.0 mg/dL by Month 6.\n\nParticipants in the trial will be randomly assigned to receive either AR882 or a placebo. The study will be double-blind, meaning neither the participants nor the investigators will know which treatment each participant is receiving. The intervention involves the administration of AR882, with the primary aim of evaluating its efficacy in lowering sUA levels and reducing tophus burden. The CAPER method will be employed to assess the response of target tophi, with evaluations conducted at Months 6 and 12 to determine the presence of disease progression.\n\nThe primary endpoint of the study is the proportion of participants achieving sUA levels below 6.0 mg/dL at Month 6. Secondary endpoints include the reduction of tophus burden and the maintenance of sUA levels below 6.0 mg/dL at Months 9 and 12, alongside the absence of gout flares over a three-month period. The trial will last until all participants have completed 12 months or have discontinued. Notable inclusion criteria include a diagnosis of gout and baseline tophi, while exclusion criteria may involve other significant health conditions that could interfere with the study's outcomes.",
                  "total_sites": 17,
                  "similarity_score": 0.7596899954635156
                },
                {
                  "id": 66,
                  "trial_name": "A Randomized, Double-blind, Multicenter, Colchicine and Placebo-controlled Study to Evaluate the Efficacy and Safety of ABP-745 in Subjects with an Acute Gout Flare",
                  "conditions": "Gout",
                  "description": "This is a Phase II, randomized, double-blind, placebo-controlled, multi-center study sponsored by Atom Therapeutics Co., Ltd.  The study will be conducted in the United States, Australia, and China and will last approximately 6 months for each participant, with the possibility of re-screening and continuing for another 6 months if no flare occurs in the initial period.  This means that neither you nor your doctor will know which treatment you are receiving, and participants will be randomly assigned to different treatment groups.  The study aims to determine how well ABP-745 works to treat acute gout flares compared to colchicine and a placebo.\n\nThis study is looking for men and women aged 18-70 with a BMI between 18 and 40 who have been diagnosed with gout and have experienced at least two gout flares in the past year.  You must be able to contact the study site and receive your first dose within 10 hours of a new flare starting, and you must be able to return to the site 24 hours after the first dose.  You will need to be able to attend several visits at the study site over a 7-day period during a flare and a final visit after treatment, as well as a safety follow-up phone call.  You may not be eligible to participate if you have certain other medical conditions or are taking certain medications.  Your doctor will discuss these criteria with you in more detail.\n\nParticipants will be randomly assigned to receive either ABP-745 (at one of two doses), colchicine, or a placebo.  The study will measure pain levels, tenderness, and swelling in your most affected joint.  The main goals are to see how much ABP-745 reduces pain at 24 hours after the first dose compared to colchicine and placebo.  Other measurements will include pain levels at later time points, the percentage of people who experience significant pain reduction, and how the treatment affects markers of inflammation in your blood.  You will take the study medication twice daily for 7 days during a flare.  You will have several visits to the study site during this time for assessments and blood draws.",
                  "investigator_name": "Dr. Taylor Sanders",
                  "site_location": "Baton Rouge, LA",
                  "protocol_summary": "This is a Phase II, randomized, double-blind, placebo-controlled, multi-center study sponsored by Atom Therapeutics Co., Ltd.  The study will be conducted in the United States, Australia, and China and will last approximately 6 months for each participant, with the possibility of re-screening and continuing for another 6 months if no flare occurs in the initial period.  This means that neither you nor your doctor will know which treatment you are receiving, and participants will be randomly assigned to different treatment groups.  The study aims to determine how well ABP-745 works to treat acute gout flares compared to colchicine and a placebo.\n\nThis study is looking for men and women aged 18-70 with a BMI between 18 and 40 who have been diagnosed with gout and have experienced at least two gout flares in the past year.  You must be able to contact the study site and receive your first dose within 10 hours of a new flare starting, and you must be able to return to the site 24 hours after the first dose.  You will need to be able to attend several visits at the study site over a 7-day period during a flare and a final visit after treatment, as well as a safety follow-up phone call.  You may not be eligible to participate if you have certain other medical conditions or are taking certain medications.  Your doctor will discuss these criteria with you in more detail.\n\nParticipants will be randomly assigned to receive either ABP-745 (at one of two doses), colchicine, or a placebo.  The study will measure pain levels, tenderness, and swelling in your most affected joint.  The main goals are to see how much ABP-745 reduces pain at 24 hours after the first dose compared to colchicine and placebo.  Other measurements will include pain levels at later time points, the percentage of people who experience significant pain reduction, and how the treatment affects markers of inflammation in your blood.  You will take the study medication twice daily for 7 days during a flare.  You will have several visits to the study site during this time for assessments and blood draws.",
                  "total_sites": 4,
                  "similarity_score": 0.7468033202522509
                }
              ],
              "trials_found": 5,
              "semantic_search": true,
              "prescreening_started": true,
              "trial_id": 14,
              "trial_name": "Clinical Trial 250-13951-306",
              "current_question_index": 3,
              "total_questions": 4,
              "current_question": "Have you been diagnosed with cancer within the past 5 years (excluding successfully treated skin cancer)?",
              "expected_answer_type": "yes_no",
              "parsed_answer": {
                "interpretation": "yes",
                "confidence": 1.0
              },
              "validation_error": true,
              "awaiting_correction": true,
              "prescreening_error": "failed_to_load_questions",
              "error_details": "No criteria found for trial 111",
              "pending_evaluation": true,
              "eligibility_result": "<coroutine object GeminiPrescreeningManager.evaluate_eligibility at 0x7fcc563114d0>",
              "summary": "\u2713 Age: 69\n\u2713 Medical history: Yes\n\u2713 Current condition: Yes\n? Medical history: Yes, I have Osteoarthritis of the Knee - needs clarification"
            },
            "response_time": 8.731301069259644,
            "timestamp": "2025-12-16T08:06:27.718262"
          },
          {
            "user_message": "Yes, please continue",
            "bot_response": "Please respond with '1' to continue with the current evaluation or '2' to make changes to your responses.",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "prescreening_review",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": "Osteoarthritis of the Knee",
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Great, thanks for confirming. The next question is: Have you previously been treated with steroid injections for your knee pain?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "boolean_answer"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening flow (state: prescreening_active) and has just answered the previous question with 'Yes'. The most appropriate action is to acknowledge their answer and proceed with the next question in the prescreening sequence. This moves the user closer to determining their eligibility for the trial. The state remains 'prescreening_active' as the process is ongoing."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "location": "Baton Rouge, LA",
              "condition": "Osteoarthritis of the Knee",
              "trials_data": [
                {
                  "id": 14,
                  "trial_name": "Clinical Trial 250-13951-306",
                  "conditions": "Female Pattern Hair Loss (Androgenetic Alopecia)",
                  "description": null,
                  "investigator_name": "Dr. Ira Thorla",
                  "site_location": "Baton Rouge, LA",
                  "protocol_summary": "This clinical trial aims to investigate the effectiveness and safety of an oral medication called VDPHL01 for treating female pattern hair loss (androgenetic alopecia).  The study will evaluate two different dosing regimens of VDPHL01: twice daily and once daily.  It will compare these regimens against a placebo to see if the medication promotes hair growth and improves patient satisfaction with their hair.\n\nWomen aged 18-65 with mild to moderate hair loss, as measured by the Savin Scale, are eligible to participate.  Key inclusion criteria include good general health, adequate kidney and liver function, and a commitment to maintaining consistent hair care routines throughout the study.  Women who are pregnant, breastfeeding, have certain medical conditions (like uncontrolled blood pressure or a history of heart problems), or have recently used other hair growth treatments are excluded.\n\nThe study will last approximately 13 months and consist of two parts. Part A is a 6-month placebo-controlled period, where participants are randomly assigned to one of four groups: VDPHL01 twice daily, VDPHL01 once daily plus placebo, placebo twice daily, or placebo twice daily.  Part B is a 6-month treatment extension, where those initially receiving placebo will start taking VDPHL01 according to their initial group assignment, while those already on VDPHL01 will continue.  Participants will have regular clinic visits (approximately 11) for assessments including physical exams, blood and urine tests, electrocardiograms, photographs of the scalp, and questionnaires about their hair and quality of life. A small group of participants will also take part in interviews.  A final follow-up will occur one month after the treatment period ends.\n",
                  "total_sites": 2,
                  "similarity_score": 0.7818238559465687
                },
                {
                  "id": 2,
                  "trial_name": "A Phase 3 Randomized, Double-blind, Multi-center, Placebo-controlled Study to Evaluate the Efficacy and Safety of AR882 in Participants with Gout",
                  "conditions": "Gout",
                  "description": "",
                  "investigator_name": "Dr. Taylor Sanders",
                  "site_location": "Baton Rouge, LA",
                  "protocol_summary": "The clinical trial, identified as Protocol AR882-301, is a Phase 3, randomized, double-blind, multi-center, placebo-controlled study designed to evaluate the efficacy and safety of the investigational drug AR882 in participants with gout. Sponsored by Arthrosi Therapeutics, Inc., this trial will be conducted across approximately 100 sites in the United States and Canada. The primary objective is to assess the ability of AR882 to reduce serum uric acid (sUA) levels in participants, with a specific focus on achieving sUA levels below 6.0 mg/dL by Month 6.\n\nParticipants in the trial will be randomly assigned to receive either AR882 or a placebo. The study will be double-blind, meaning neither the participants nor the investigators will know which treatment each participant is receiving. The intervention involves the administration of AR882, with the primary aim of evaluating its efficacy in lowering sUA levels and reducing tophus burden. The CAPER method will be employed to assess the response of target tophi, with evaluations conducted at Months 6 and 12 to determine the presence of disease progression.\n\nThe primary endpoint of the study is the proportion of participants achieving sUA levels below 6.0 mg/dL at Month 6. Secondary endpoints include the reduction of tophus burden and the maintenance of sUA levels below 6.0 mg/dL at Months 9 and 12, alongside the absence of gout flares over a three-month period. The trial will last until all participants have completed 12 months or have discontinued. Notable inclusion criteria include a diagnosis of gout and baseline tophi, while exclusion criteria may involve other significant health conditions that could interfere with the study's outcomes.",
                  "total_sites": 17,
                  "similarity_score": 0.7596899954635156
                },
                {
                  "id": 66,
                  "trial_name": "A Randomized, Double-blind, Multicenter, Colchicine and Placebo-controlled Study to Evaluate the Efficacy and Safety of ABP-745 in Subjects with an Acute Gout Flare",
                  "conditions": "Gout",
                  "description": "This is a Phase II, randomized, double-blind, placebo-controlled, multi-center study sponsored by Atom Therapeutics Co., Ltd.  The study will be conducted in the United States, Australia, and China and will last approximately 6 months for each participant, with the possibility of re-screening and continuing for another 6 months if no flare occurs in the initial period.  This means that neither you nor your doctor will know which treatment you are receiving, and participants will be randomly assigned to different treatment groups.  The study aims to determine how well ABP-745 works to treat acute gout flares compared to colchicine and a placebo.\n\nThis study is looking for men and women aged 18-70 with a BMI between 18 and 40 who have been diagnosed with gout and have experienced at least two gout flares in the past year.  You must be able to contact the study site and receive your first dose within 10 hours of a new flare starting, and you must be able to return to the site 24 hours after the first dose.  You will need to be able to attend several visits at the study site over a 7-day period during a flare and a final visit after treatment, as well as a safety follow-up phone call.  You may not be eligible to participate if you have certain other medical conditions or are taking certain medications.  Your doctor will discuss these criteria with you in more detail.\n\nParticipants will be randomly assigned to receive either ABP-745 (at one of two doses), colchicine, or a placebo.  The study will measure pain levels, tenderness, and swelling in your most affected joint.  The main goals are to see how much ABP-745 reduces pain at 24 hours after the first dose compared to colchicine and placebo.  Other measurements will include pain levels at later time points, the percentage of people who experience significant pain reduction, and how the treatment affects markers of inflammation in your blood.  You will take the study medication twice daily for 7 days during a flare.  You will have several visits to the study site during this time for assessments and blood draws.",
                  "investigator_name": "Dr. Taylor Sanders",
                  "site_location": "Baton Rouge, LA",
                  "protocol_summary": "This is a Phase II, randomized, double-blind, placebo-controlled, multi-center study sponsored by Atom Therapeutics Co., Ltd.  The study will be conducted in the United States, Australia, and China and will last approximately 6 months for each participant, with the possibility of re-screening and continuing for another 6 months if no flare occurs in the initial period.  This means that neither you nor your doctor will know which treatment you are receiving, and participants will be randomly assigned to different treatment groups.  The study aims to determine how well ABP-745 works to treat acute gout flares compared to colchicine and a placebo.\n\nThis study is looking for men and women aged 18-70 with a BMI between 18 and 40 who have been diagnosed with gout and have experienced at least two gout flares in the past year.  You must be able to contact the study site and receive your first dose within 10 hours of a new flare starting, and you must be able to return to the site 24 hours after the first dose.  You will need to be able to attend several visits at the study site over a 7-day period during a flare and a final visit after treatment, as well as a safety follow-up phone call.  You may not be eligible to participate if you have certain other medical conditions or are taking certain medications.  Your doctor will discuss these criteria with you in more detail.\n\nParticipants will be randomly assigned to receive either ABP-745 (at one of two doses), colchicine, or a placebo.  The study will measure pain levels, tenderness, and swelling in your most affected joint.  The main goals are to see how much ABP-745 reduces pain at 24 hours after the first dose compared to colchicine and placebo.  Other measurements will include pain levels at later time points, the percentage of people who experience significant pain reduction, and how the treatment affects markers of inflammation in your blood.  You will take the study medication twice daily for 7 days during a flare.  You will have several visits to the study site during this time for assessments and blood draws.",
                  "total_sites": 4,
                  "similarity_score": 0.7468033202522509
                }
              ],
              "trials_found": 5,
              "semantic_search": true,
              "prescreening_started": true,
              "trial_id": 14,
              "trial_name": "Clinical Trial 250-13951-306",
              "current_question_index": 3,
              "total_questions": 4,
              "current_question": "Have you been diagnosed with cancer within the past 5 years (excluding successfully treated skin cancer)?",
              "expected_answer_type": "yes_no",
              "parsed_answer": {
                "interpretation": "yes",
                "confidence": 1.0
              },
              "validation_error": true,
              "awaiting_correction": true,
              "prescreening_error": "failed_to_load_questions",
              "error_details": "No criteria found for trial 111",
              "pending_evaluation": true,
              "eligibility_result": "<coroutine object GeminiPrescreeningManager.evaluate_eligibility at 0x7fcc563114d0>",
              "summary": "\u2713 Age: 69\n\u2713 Medical history: Yes\n\u2713 Current condition: Yes\n? Medical history: Yes, I have Osteoarthritis of the Knee - needs clarification"
            },
            "response_time": 8.329439163208008,
            "timestamp": "2025-12-16T08:06:36.048160"
          },
          {
            "user_message": "Yes, please continue",
            "bot_response": "Please respond with '1' to continue with the current evaluation or '2' to make changes to your responses.",
            "metadata": {
              "session_id": "AUTO_TEST_random_000",
              "current_state": "prescreening_review",
              "handler_used": "GeminiConversationManager",
              "processing_method": "gemini_conversation_manager",
              "action_type": "continue_prescreening",
              "entities_collected": {
                "condition": "Osteoarthritis of the Knee",
                "location": null,
                "age": null,
                "medication": null,
                "number": null,
                "trial_name": null,
                "boolean_answer": true,
                "confidence_scores": {}
              },
              "conversation_action": {
                "action_type": "continue_prescreening",
                "parameters": {},
                "response_text": "Great, thanks for confirming. The next question is: Have you previously been treated with steroid injections for your knee pain?",
                "new_state": "prescreening_active",
                "collect_entities": [
                  "boolean_answer"
                ],
                "metadata": {
                  "reasoning": "The user is in an active prescreening flow (state: prescreening_active) and has just answered the previous question with 'Yes'. The most appropriate action is to acknowledge their answer and proceed with the next question in the prescreening sequence. This moves the user closer to determining their eligibility for the trial. The state remains 'prescreening_active' as the process is ongoing."
                }
              },
              "user_analysis": {
                "sentiment": "neutral",
                "communication_style": "standard",
                "complexity_preference": "moderate"
              },
              "location": "Baton Rouge, LA",
              "condition": "Osteoarthritis of the Knee",
              "trials_data": [
                {
                  "id": 14,
                  "trial_name": "Clinical Trial 250-13951-306",
                  "conditions": "Female Pattern Hair Loss (Androgenetic Alopecia)",
                  "description": null,
                  "investigator_name": "Dr. Ira Thorla",
                  "site_location": "Baton Rouge, LA",
                  "protocol_summary": "This clinical trial aims to investigate the effectiveness and safety of an oral medication called VDPHL01 for treating female pattern hair loss (androgenetic alopecia).  The study will evaluate two different dosing regimens of VDPHL01: twice daily and once daily.  It will compare these regimens against a placebo to see if the medication promotes hair growth and improves patient satisfaction with their hair.\n\nWomen aged 18-65 with mild to moderate hair loss, as measured by the Savin Scale, are eligible to participate.  Key inclusion criteria include good general health, adequate kidney and liver function, and a commitment to maintaining consistent hair care routines throughout the study.  Women who are pregnant, breastfeeding, have certain medical conditions (like uncontrolled blood pressure or a history of heart problems), or have recently used other hair growth treatments are excluded.\n\nThe study will last approximately 13 months and consist of two parts. Part A is a 6-month placebo-controlled period, where participants are randomly assigned to one of four groups: VDPHL01 twice daily, VDPHL01 once daily plus placebo, placebo twice daily, or placebo twice daily.  Part B is a 6-month treatment extension, where those initially receiving placebo will start taking VDPHL01 according to their initial group assignment, while those already on VDPHL01 will continue.  Participants will have regular clinic visits (approximately 11) for assessments including physical exams, blood and urine tests, electrocardiograms, photographs of the scalp, and questionnaires about their hair and quality of life. A small group of participants will also take part in interviews.  A final follow-up will occur one month after the treatment period ends.\n",
                  "total_sites": 2,
                  "similarity_score": 0.7818238559465687
                },
                {
                  "id": 2,
                  "trial_name": "A Phase 3 Randomized, Double-blind, Multi-center, Placebo-controlled Study to Evaluate the Efficacy and Safety of AR882 in Participants with Gout",
                  "conditions": "Gout",
                  "description": "",
                  "investigator_name": "Dr. Taylor Sanders",
                  "site_location": "Baton Rouge, LA",
                  "protocol_summary": "The clinical trial, identified as Protocol AR882-301, is a Phase 3, randomized, double-blind, multi-center, placebo-controlled study designed to evaluate the efficacy and safety of the investigational drug AR882 in participants with gout. Sponsored by Arthrosi Therapeutics, Inc., this trial will be conducted across approximately 100 sites in the United States and Canada. The primary objective is to assess the ability of AR882 to reduce serum uric acid (sUA) levels in participants, with a specific focus on achieving sUA levels below 6.0 mg/dL by Month 6.\n\nParticipants in the trial will be randomly assigned to receive either AR882 or a placebo. The study will be double-blind, meaning neither the participants nor the investigators will know which treatment each participant is receiving. The intervention involves the administration of AR882, with the primary aim of evaluating its efficacy in lowering sUA levels and reducing tophus burden. The CAPER method will be employed to assess the response of target tophi, with evaluations conducted at Months 6 and 12 to determine the presence of disease progression.\n\nThe primary endpoint of the study is the proportion of participants achieving sUA levels below 6.0 mg/dL at Month 6. Secondary endpoints include the reduction of tophus burden and the maintenance of sUA levels below 6.0 mg/dL at Months 9 and 12, alongside the absence of gout flares over a three-month period. The trial will last until all participants have completed 12 months or have discontinued. Notable inclusion criteria include a diagnosis of gout and baseline tophi, while exclusion criteria may involve other significant health conditions that could interfere with the study's outcomes.",
                  "total_sites": 17,
                  "similarity_score": 0.7596899954635156
                },
                {
                  "id": 66,
                  "trial_name": "A Randomized, Double-blind, Multicenter, Colchicine and Placebo-controlled Study to Evaluate the Efficacy and Safety of ABP-745 in Subjects with an Acute Gout Flare",
                  "conditions": "Gout",
                  "description": "This is a Phase II, randomized, double-blind, placebo-controlled, multi-center study sponsored by Atom Therapeutics Co., Ltd.  The study will be conducted in the United States, Australia, and China and will last approximately 6 months for each participant, with the possibility of re-screening and continuing for another 6 months if no flare occurs in the initial period.  This means that neither you nor your doctor will know which treatment you are receiving, and participants will be randomly assigned to different treatment groups.  The study aims to determine how well ABP-745 works to treat acute gout flares compared to colchicine and a placebo.\n\nThis study is looking for men and women aged 18-70 with a BMI between 18 and 40 who have been diagnosed with gout and have experienced at least two gout flares in the past year.  You must be able to contact the study site and receive your first dose within 10 hours of a new flare starting, and you must be able to return to the site 24 hours after the first dose.  You will need to be able to attend several visits at the study site over a 7-day period during a flare and a final visit after treatment, as well as a safety follow-up phone call.  You may not be eligible to participate if you have certain other medical conditions or are taking certain medications.  Your doctor will discuss these criteria with you in more detail.\n\nParticipants will be randomly assigned to receive either ABP-745 (at one of two doses), colchicine, or a placebo.  The study will measure pain levels, tenderness, and swelling in your most affected joint.  The main goals are to see how much ABP-745 reduces pain at 24 hours after the first dose compared to colchicine and placebo.  Other measurements will include pain levels at later time points, the percentage of people who experience significant pain reduction, and how the treatment affects markers of inflammation in your blood.  You will take the study medication twice daily for 7 days during a flare.  You will have several visits to the study site during this time for assessments and blood draws.",
                  "investigator_name": "Dr. Taylor Sanders",
                  "site_location": "Baton Rouge, LA",
                  "protocol_summary": "This is a Phase II, randomized, double-blind, placebo-controlled, multi-center study sponsored by Atom Therapeutics Co., Ltd.  The study will be conducted in the United States, Australia, and China and will last approximately 6 months for each participant, with the possibility of re-screening and continuing for another 6 months if no flare occurs in the initial period.  This means that neither you nor your doctor will know which treatment you are receiving, and participants will be randomly assigned to different treatment groups.  The study aims to determine how well ABP-745 works to treat acute gout flares compared to colchicine and a placebo.\n\nThis study is looking for men and women aged 18-70 with a BMI between 18 and 40 who have been diagnosed with gout and have experienced at least two gout flares in the past year.  You must be able to contact the study site and receive your first dose within 10 hours of a new flare starting, and you must be able to return to the site 24 hours after the first dose.  You will need to be able to attend several visits at the study site over a 7-day period during a flare and a final visit after treatment, as well as a safety follow-up phone call.  You may not be eligible to participate if you have certain other medical conditions or are taking certain medications.  Your doctor will discuss these criteria with you in more detail.\n\nParticipants will be randomly assigned to receive either ABP-745 (at one of two doses), colchicine, or a placebo.  The study will measure pain levels, tenderness, and swelling in your most affected joint.  The main goals are to see how much ABP-745 reduces pain at 24 hours after the first dose compared to colchicine and placebo.  Other measurements will include pain levels at later time points, the percentage of people who experience significant pain reduction, and how the treatment affects markers of inflammation in your blood.  You will take the study medication twice daily for 7 days during a flare.  You will have several visits to the study site during this time for assessments and blood draws.",
                  "total_sites": 4,
                  "similarity_score": 0.7468033202522509
                }
              ],
              "trials_found": 5,
              "semantic_search": true,
              "prescreening_started": true,
              "trial_id": 14,
              "trial_name": "Clinical Trial 250-13951-306",
              "current_question_index": 3,
              "total_questions": 4,
              "current_question": "Have you been diagnosed with cancer within the past 5 years (excluding successfully treated skin cancer)?",
              "expected_answer_type": "yes_no",
              "parsed_answer": {
                "interpretation": "yes",
                "confidence": 1.0
              },
              "validation_error": true,
              "awaiting_correction": true,
              "prescreening_error": "failed_to_load_questions",
              "error_details": "No criteria found for trial 111",
              "pending_evaluation": true,
              "eligibility_result": "<coroutine object GeminiPrescreeningManager.evaluate_eligibility at 0x7fcc563114d0>",
              "summary": "\u2713 Age: 69\n\u2713 Medical history: Yes\n\u2713 Current condition: Yes\n? Medical history: Yes, I have Osteoarthritis of the Knee - needs clarification"
            },
            "response_time": 13.11014699935913,
            "timestamp": "2025-12-16T08:06:49.158992"
          }
        ],
        "final_state": "completed",
        "total_turns": 9,
        "total_questions_asked": 4,
        "errors": [
          {
            "type": "unexpected_state",
            "bot_response": "Please respond with '1' to continue with the current evaluation or '2' to make changes to your respo"
          },
          {
            "type": "unexpected_state",
            "bot_response": "Please respond with '1' to continue with the current evaluation or '2' to make changes to your respo"
          }
        ]
      },
      "validation": {
        "passed": false,
        "overall_score": 70.0,
        "crash_prevention": {
          "passed": true,
          "score": 100.0,
          "error_count": 0,
          "errors": [],
          "failures": []
        },
        "eligibility_accuracy": {
          "passed": false,
          "score": 0.0,
          "reason": "Could not extract eligibility result",
          "failures": [
            {
              "type": "eligibility_logic_error",
              "reason": "No eligibility determination found in conversation",
              "likely_location": "core/prescreening/gemini_prescreening_manager.py:evaluate_eligibility()",
              "severity": "high"
            }
          ]
        },
        "conversation_quality": {
          "passed": true,
          "score": 100.0,
          "total_questions_asked": 4,
          "issues": [],
          "failures": []
        },
        "edge_case_handling": {
          "passed": true,
          "score": 100.0,
          "applicable": false,
          "failures": []
        },
        "performance": {
          "passed": false,
          "score": 40.0,
          "avg_response_time": 24.159877644644844,
          "max_response_time": 58.95304012298584,
          "status": "slow",
          "failures": [
            {
              "type": "performance_issue",
              "avg_response_time": 24.159877644644844,
              "max_response_time": 58.95304012298584,
              "severity": "low",
              "recommendation": "Investigate slow API responses or Gemini API delays"
            }
          ]
        },
        "failure_points": [
          {
            "type": "eligibility_logic_error",
            "reason": "No eligibility determination found in conversation",
            "likely_location": "core/prescreening/gemini_prescreening_manager.py:evaluate_eligibility()",
            "severity": "high"
          },
          {
            "type": "performance_issue",
            "avg_response_time": 24.159877644644844,
            "max_response_time": 58.95304012298584,
            "severity": "low",
            "recommendation": "Investigate slow API responses or Gemini API delays"
          }
        ],
        "recommendations": [
          "\u26a0\ufe0f HIGH: Review eligibility evaluation logic in gemini_prescreening_manager.py",
          "\u2139\ufe0f LOW: Slow response times. Optimize API calls or consider caching."
        ]
      },
      "timestamp": "2025-12-16T08:06:49.159467"
    }
  ]
}